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Abstract 
The purpose of this study was to investigate the effects of a creatine and electrolyte 
formulated multi-ingredient performance supplement (MIPS) on strength and power 
performance. Maximal strength, total concentric work, mean rate of force development 
(mRFD), mean power, peak power, and peak force was determined at pre-test and post-test 
separated by six weeks of supplementation. Subject’s body density and body water were 
measured using a BodPod and Quantum X Bioelectrical Impedance unit respectively. 
Subjects performed three akimbo countermovement jumps (ACMJ) on a force platform. 
Subjects performed a one-repetition maximum (1RM) for back squat and bench press 
consisting of a maximal repetition test at a 90% predicted value. Eighty percent of the 
subjects pre-test 1RM was used for a maximal repetition test to test for performance variables 
including: total concentric work, mRFD, mean power, peak power, and peak force. Testing 
was separated by six weeks of supplementation in a double blind fashion with a placebo 
group for comparison. A two way mixed analysis of variance (ANOVA) was applied with an 
alpha level of 0.05 for all body composition, body water, akimbo countermovement jump, 
back squat, and bench press variables. The MIPS showed a significant increased back squat 
and bench press maximal strength (13.4%, p = 0.035 and 5.9%, p = 0.045 respectively), as 
well as total concentric work (26.5%, p = 0.024), mRFD (22.4%, p = 0.050), and mean 
power (17.9%, p = 0.025) for the maximal repetition bench press test at 80% of their 1RM. 
The placebo group had a significant decreased mRFD of -26% over the six-week 
supplementation. Creatine formulated with electrolytes could be beneficial for recreationally 
trained individuals.  
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Chapter I 
The Problem and Its Scope 
Introduction 
 The human body utilizes various energy systems to generate human movement under 
different circumstances. These systems can be split into two categories, aerobic and 
anaerobic energy systems (Bemben, Bemben, Loftiss & Knehans, 2001; Larson-Meyer et al., 
2000). Aerobic energy systems are utilized for prolonged exercise that utilizes oxygen to 
generate a large amount of adenosine triphosphate (ATP) (Bemben et al., 2010). A primary 
system that generates ATP under very quick and acute circumstances is the creatine 
phosphagen system. It has been determined that increasing the storage of free creatine and 
creatine phosphates can help prolong the usage of the creatine phosphagen system. 
Supplementation of creatine enhances the total storage of creatine and helps increase both 
power and strength performances (Aedma, Timpmann, Lätt, & Ööpik, 2015; Greenhaff, 
Bodin, Soderlund, & Hultman, 1994; Wiroth et al., 2001).  
 Creatine supplementation has become a very popular supplement among athletes and 
recreationally trained people for decades (Brenner, Rankin, & Sebolt, 2000; Claudino et al., 
2014; McGuine, Sullivan, & Bernhardt, 2001). Supplementation of creatine has also become 
wide spread across varying skill levels of athletes, ranging from recreational to professional 
levels (Antonio & Ciccone, 2013; Bemben et al., 2010; Vincent & Jenkins, 1998). Creatine is 
primarily found in the human body to support movement through a fast activation energy 
system known as the creatine phosphagen system (Aedma et al., 2015; Becque, Lochmann, 
& Melrose, 2000; Kresta et al., 2014). The creatine phosphagen system is used by the human 
body for short duration activity using creatine phosphates as a source of fuel to produce 
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Adenosine Triphosphate (ATP) for bodily movement. Adenosine Diphosphate (ADP) is 
phosphorylated using phosphocreatine and transformed into ATP which is used for muscular 
movement. The creatine phosphate system is an acute pathway for metabolic energy only 
lasting for about ten seconds prior to being depleted (Becque et al., 2000; Hoffman et al., 
2006).  
Supplementation involving creatine is used by many people to enhance characteristics 
of their performance in physical activity. Creatine supplementation has been previously used 
to increase various aspects of both power and strength activities (Earnest, Snell, Rodrigues, 
Almada, & Mitchell, 1995; Francaux & Poortmans, 1999; Peeters, Lantz, & Mayhew, 1999). 
Most of the literature on creatine supplementation appears to support the trend that this 
supplementation is beneficial for a wide variety of people for several reasons. Multiple 
studies have concluded that creatine supplementation ranging from one week to twelve 
weeks can be helpful in enhancing one-repetition maximum strength, total work capacity, 
increasing lean-body mass, and, in some cases, increases in lower limb power output 
(Claudino et al., 2014; Earnest et al., 1995; Herda et al., 2009).  
The most common form of creatine supplementation comes in the form of creatine 
monohydrate (Francaux et al., 1999; Kreider et al., 1998). Research has varied on the 
dosages required to elicit benefits from creatine supplementation, ranging from 20g/day for 
loading phases to 3g/day for maintenance dosages (Barros et al., 2012; Olsen et al., 2006; 
Robinson, 2000). While some studies have combined the use of creatine supplementation 
with beta alanine and other solutions, there is very little to no literature on creatine 
supplementation coupled with electrolytes. Electrolytes such as sodium, potassium, and 
magnesium are transporters used to aid in the absorption and utilization of creatine by the 
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human body (Allen, 2012). The current study aims to investigate the potential effects of a 
creatine supplement combined with various electrolytes for body composition, body water 
analysis, power, and strength outcomes for college-aged individuals.  
Purpose of the Study 
 The purpose of this study was to examine the effects of a multi-ingredient 
performance supplement comprised of electrolytes and creatine on the performance of 
individuals who are regularly strength training. The primary purpose of the study was to 
examine the potential benefits of the multi-ingredient performance supplement (MIPS) 
supplementation on power and strength performance outcomes during an akimbo 
countermovement jump, and the back squat, and bench press exercises. The study was aimed 
at examining the implications for performance enhancement in an active population that 
would benefit or would potentially use supplementation for enhancement.  
Hypothesis 
 We hypothesized that a six-week supplementation period of the MIPS would 
increase:  lean body mass (LBM), intra-cellular water, peak and mean power for an akimbo 
countermovement jump (ACMJ), and increase predicted one-repetition maximum (1RM) 
strength for back squat and bench press. Additionally, there will be an increase the amount of 
concentric work, mean power, peak power, mean rate of force development, and peak force 
for back squat and bench press during a maximal repetition test at 80% 1RM load.  
 
Significance of the Study 
 Creatine is one of the most researched supplements to help enhance performance 
across many activities (Bemben et al., 2001; Greenhaff et al., 1994; Jagim et al., 2012; 
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Larson-Meyer et al., 2000; McGuine et al., 2001). Specifically, creatine has been used to 
enhance performance in various settings for both strength and power activities. Currently, 
there are very few studies that examine the effects of a specific MIPS such as this one, 
formulated with electrolytes and creatine. The ideology is that the MIPS will allow for 
greater absorption and utilization of the creatine dosage due to increased availability of 
electrolytes used for cell transportation. This study will give insight to possible adaptations to 
the supplementation procedure using creatine.   
Limitations 
 This study is unable to account for subject history and experience with specific 
exercises. Familiarity with either the back squat or bench press could have had an 
effect on the outcome measures.  
 All testing occurred inside of a laboratory setting and may not be applicable to real 
world settings. The maintenance of internal validity caused a decrease in external 
validity. 
  Subjects were self-reporting their own adherence when taking their assigned 
supplement.  
 Back squat range of motion or depth was not controlled in the one repetition max 
testing or the maximal repetition test.  
 The load used for the maximal repetition test was kept consistent to give an accurate 
comparison between the pre-test to post-test. Subjects could have either increased or 
decreased the 1RM strength and the 80% 1RM could have been adjusted for with the 
post-test 1RM value.  
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Definition of Terms 
Akimbo 
Countermovement 
Jump 
A maximal effort jump including an unweighting period and 
loading while keeping hands fixed on their hips. (Claudino et al., 
2014) 
Body Composition Measurements used to describe the overall make up of a person’s 
body in terms of body fat and fat free mass.  (Jagim et al., 2012) 
Center of Mass The most central point of an object mass at which the mass is 
even distributed around. (Lukos, Ansuini, & Stantello, 2007) 
Creatine Phosphagen 
System  
The acute metabolic energy pathway in which ADP is 
phosphorylated using creatine phosphate into ATP. This is a very 
short term energy system only lasting a couple of seconds before 
needing to be replenished. (Allen, 2012) 
Concentric Work 
 
The product of a force applied to an object that also results in 
displacement or movement of said object. (Work = Force * 
Displacement * cosine(theta)) (Wiroth et al., 2001) 
Dosage Amount of a certain substance taken prescribed in an amount of 
grams per day for supplementation (Aedma et al., 2015; 
Greenhaff et al., 1994; Wiroth et al., 2001) 
Electrolytes A group of minerals that are found in the body. Aids in 
membrane transportation. (Allen, 2012) 
Extra-cellular Water Physiological measurement of the amount of water that exists 
outside of an individual’s cells. (Francaux et al., 1999) 
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Force An interaction that when unopposed can cause a change in 
direction. (Force = Mass x Acceleration) (Francaux et al., 1999) 
Intra-cellular Water Physiological measurement of the amount of water that exists 
inside of an individual’s cells. (Francaux et al., 1999) 
Lean Body Mass 
(LBM) 
The amount of body tissue that is attributed to be free of adipose 
tissue. Used in a two compartment model with fat mass to 
describe the overall make up of individuals body. (Francaux et 
al., 1999) 
One-Repetition 
Maximum (1RM) 
The load that someone can only perform for a single time before 
failure, used a value for maximal strength (Bemben et al., 2010) 
Power The rate at which an amount of work takes place during a 
specified movement (Power = Force*Velocity) (Claudino et al., 
2014) 
Rate of Force 
Development (RFD) 
The speed at which and individual reaches their peak force 
expressed in the units of N/s (Mikrov et al., 2016) 
Time in Flight  The amount of time someone is airborne during a jumping task, 
measured in seconds. (Noonan, Berg, Latin, Wagner, & Reimers, 
1998) 
Total Body Water Physiological measurement of the total amount of water stored in 
an individual’s body. A combination of both intra-cellular and 
extra-cellular waters. (Francaux et al., 1999) 
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Chapter II 
Review of the Literature 
Introduction 
  Creatine has become one of the most researched and well-known products used for 
supplementation (Aedma et al., 2015; Jagim et al., 2012; Kresta et al., 2014; Olsen et al., 
2006). Creatine is widely known for its ability to enhance performance in both strength and 
power activities. Creatine supplementation aids in boosting and enhancing the performance 
of ATP generation through the phosphorylation of ADP using the creatine phosphagen 
system (Hultman, Söderlund, Timmons, Cederblad, & Greenhaff, 1996; Zuniga et al., 2012). 
Creatine supplementation daily has become a common routine with the dosages ranging from 
20g/day to as little as 3g/day (Allen, 2012; Larson-Meyer et al., 2000; Robinson, 2000). 
Research has concluded that while the dosage range does not play a critical factor, any 
supplementation of creatine can prove to be beneficial (Allen, 2012; Brenner et al., 2000; 
Robinson, 2000). Individuals using creatine as supplementation increase overall maximum 
strength, maximal repetition strength, as well as power output (Cooper et al., 2013; del 
Favero et al., 2012; Souza-Junior et al., 2012; Wiroth et al., 2001; Zuniga et al., 2012).  
 While creatine on its own is beneficial, there is little to no research on creatine 
coupled with electrolytes. Electrolytes are a common mineral that aids in cell transportation 
of creatine, which plays a critical role in creatine absorption (Allen, 2012; Greenhaff et al., 
1994). The current study aims to examine the effect of a creatine and electrolyte supplement 
compared to a placebo group on maximal strength, power, and performance while 
performing a maximal bench press and back squat set at 80% 1RM load.  
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Review of the Literature 
 Creatine. Creatine is created and stored in the body to be used for fast acting 
Adenosine Triphosphate (ATP) generation via the creatine phosphagen (CP) system that 
phosphorylates ADP. The human body generates a basal amount of creatine daily and stores 
them as creatine phosphate and free creatine (Greenhaff et al., 1994; Robinson, 2000). The 
CP system for energy is very short term. Most research has found that the CP system is 
depleted by ten seconds of acute activity (Greenhaff et al., 1994; Jagim et al., 2012).  
 Creatine supplementation helps increase the rate of muscular creatine resynthesize 
(Greenhaff et al., 1994). The body is able to resynthesize muscular creatine at an increased 
rate of 19±4 mmol/dry matter following an acute supplementation of five days. Once 
muscular creatine has been depleted through exercise, the CP system is unable to 
appropriately produce energy until the muscular creatine is resynthesized. Creatine 
supplementation displays a key role in aiding the rate and amount of creatine resynthesis 
when preforming physical activity.  
 Creatine and electrolytes: multi-ingredient performance supplements. Creatine 
absorption highly depends on electrolytes such as sodium and chloride availability and usage 
as active transporters (Allen, 2012). Allen, (2012) described that sodium and chloride ions 
are necessary to actively transport creatine from the blood plasma into the musculature, 
increasing the amount of creatine storage available for use.  Based on creatine transportation, 
other researchers have examined the effects of combining both creatine and electrolytes such 
as sodium and magnesium for performance benefits (Barber, McDermott, McGaughey, 
Olmstead, & Hagobian, 2013; Brilla, Giroux, Taylor, & Knutzen, 2003; Mero, Keskinen, 
Malyela, & Sallinen, 2004).  
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Supplementing with both creatine and electrolytes such as sodium has been used to 
increase creatine transportation (Mero et al., 2004). Mero et al. (2004) found that 
supplementing with creatine combined with sodium bicarbonate enhances maximal swim 
tests, approximately 0.9 seconds faster than the placebo group. A similar study used creatine 
monohydrate combined with sodium bicarbonate compared to creatine supplementation 
alone during six 10-second wingate tests (Barber et al., 2013). The creatine and sodium 
bicarbonate group displayed a 7% increase in peak power compared to a 4% increase in the 
creatine only group. The group supplementing with both creatine and sodium bicarbonate 
had their power levels significantly higher than both the placebo and creatine groups during 
the six repeated bouts of cycling (Barber et al., 2013). The combined creatine and sodium 
bicarbonate only saw a decrease of power on the sixth bout whereas the other groups had 
decreases in bouts four, five, and six.  
 Another study examined the effects of a creatine supplement formulated with 
magnesium over two weeks. Subjects were given either a placebo, magnesium oxide with 
creatine, or magnesium-creatine chelate (Brilla et al., 2003). Following supplementation, 
subjects had an increased: intra-cellular water (26.29 L to 28.01 L) and increase quadriceps 
torque (124.5 to 135.8 Nm). The magnesium-creatine chelate was the only group to display a 
significant change over time for peak torques compared to both the placebo or magnesium 
oxide plus creatine groups (Brilla et al., 2003).  
Creatine supplementation. Creatine supplementation works to enhance the 
availability of creatine for absorption and utilization by the cell (Brenner et al., 2000). By 
increasing the amount of free creatine in the system, creatine supplementation aids in 
increasing the amount of creatine phosphates stored in the muscle to prolong the use of the 
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CP system for ATP generation (Greenhaff et al., 1994). The supplementation is taken orally 
in daily doses to increase the total creatine available for absorption. Due to the enhancement 
of the CP system, creatine supplementation increases multiple fitness and sport activities 
revolving around acute bouts of exercise (Cooper et al., 2013). Due to the availability of 
creatine supplements, the use of creatine is very wide spread across ages, sports, and skill 
levels.  
 A 2001 survey and research article found that out of 1,349 high school football 
players, about 30% responded as taking creatine supplementation (McGuine et al., 2001). Of 
those who responded as taking creatine, the highest numbers were those in the 12th grade at 
50.5% (McGuine et al., 2001).  Creatine supplementation has been further researched in high 
skill groups including NCAA division I athletes, professional Brazilian soccer players, and 
NCAA division I female soccer players (Bemben et al., 2001; Larson-Meyer et al., 2000). 
The extent of creatine supplementation reaches far and includes individuals in all sports and 
activities.  
 Creatine supplementation is also separated into three variables that are controlled for: 
the frequency, amount, and timing of supplementation. Researchers continue to examine the 
effect of creatine based off a daily dose taken by participants and athletes (Bemben et al., 
2010; Larson-Meyer et al., 2000; Vandenberghe et al., 1997). Taken daily, creatine 
supplements increase the amount of PCr available for use in the CP system to produce ATP. 
The timing of ingestion also seems to play a small role in the effectiveness of the 
supplement. It was found that taking a creatine supplement post work out was more 
beneficial at increasing 1RM bench press strength compared to pre-workout (Antonio & 
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Ciccone, 2013). While the frequency of supplementation seems to not vary at all or little, the 
dosages taken by individuals are a topic of much debate for benefits and risks.  
 Dosage of creatine. The dosage of creatine supplementation is widely debated. 
Primarily, creatine dosages depends on the phase of loading, either a loading dosage phase or 
maintenance dosage phase (Aedma et al., 2015; Herda et al., 2009; Jagim et al., 2012). A 
loading dosage phase has subjects ingesting a large amount of creatine daily in the hopes of a 
rapid increase in PCr to elicit very rapid changes in performance (Aedma et al., 2015; 
Greenhaff et al., 1994; Wiroth et al., 2001). The typical loading dosage shown in previous 
research is 20g/day separated into multiple doses per day. Maintenance phases of creatine 
supplementation typically range from 3g/day to 5g/day (Robinson, 2000; Syrotuik et al., 
2000).  
A study involving college female lacrosse players used a dosage of 5g/day for four 
times daily for one week (Brenner et al., 2000). Another study examining creatine’s effect 
over nine weeks in NCAA division I football players used 4g/day for five times daily for a 
period of five days. After the five days, a maintenance dosage of 5g/day was used for the 
remainder of their study (Bemben et al., 2001). Vandenberghe et al. (1997) examined the 
effects of creatine on nineteen female participants over a ten-week period, and both a loading 
phase followed by a maintenance phase dosage. Following four days of supplementation for 
20g/day, the subjects displayed a 6% increase in their PCr concentration (p<0.05) and was 
maintained with a dosage of 5g/day. However, during their loading phase, the rate of creatine 
excretion was greatly increased to about 7-11g/day.  
There is some research that shows even using an average maintenance dose over a 
prolonged period yields similar results compared to using a loading dose (Herda et al., 2009; 
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Peeters et al., 1999). A study examining muscular strength and satellite cell numbers only 
used a dose of 6g/day and found increases in maximal isometric strength performance from 
307.2 ± 25.9 to 371.8 ± 69.7 N/m (p<0.001). Hultman et al. (1996) specifically compared the 
muscle creatine increases between using a loading phase vs. only maintenance level doses in 
31 male subjects. After supplementing 20g/day of creatine monohydrate, the men saw an 
increase of 20% of their stored muscular creatine. This increase was maintained using a dose 
of 2g/day for the remainder 30 days. The loading dose group did similarly see an increase in 
their creatine excretion via urine during the 20g/day dosage phase. Subjects who only 
ingested 3g/day for 30 days also saw a similar increase of 20% in muscular creatine storage.  
When compared, there were no displays of renal, hepatic, or muscular damage for 
either loading dosages of creatine versus a dosage equal to maintenance levels (Robinson, 
2000). The study compared the risks and effects of creatine supplementation of 20g/day for 
five days and 3g/day for nine weeks. Blood samples were used for analysis for analysis of the 
acute and chronic time points of creatine supplementation. All of the measurements were 
within normal ranges of healthy individuals, indicating no increased risk of creatine 
supplementation for either dose. There were also increases of muscular creatine 
concentration in both supplementation groups when compared to pre-testing.  
Creatine supplementation doses vary depending on the circumstances and individuals 
deciding to take the supplement. Dosages vary from very large daily amounts up to 20g/day 
for a loading phase to a smaller amount of 3g/day for a maintenance phase. Both dosage 
schemes increase the creatine concentration in healthy individuals with no apparent health 
risk. People taking large loading doses appear to excrete a much larger volume of about 7 to 
11g/day of creatine in their urine when compared to healthy people not taking creatine. 
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Overall, creatine supplementation of any dosage will have a positive effect on performance, 
with greater doses being excreted at larger amounts.  
 Creatine effects on body composition. Creatine supplements have been boasted to 
improve body composition with increasing the amount of lean body mass (Kresta et al., 
2014). Increased muscular creatine allows for an increase in work capacity and intensity, 
giving individuals increased capacity for increasing lean body mass (Jagim et al., 2012). 
However, research does conflict on the effects of creatine on body composition either 
displaying no change over time or very slight changes in lean body mass (LBM).  
 A 28 day creatine supplementation study on active female participants displayed that 
supplementation only had an effect on LBM over time but no interaction between the placebo 
group (Kresta et al., 2014). Another study examined the effects of creatine monohydrate 
(Creapure) and Kre-Alkalyn, alkaline creatine with soda ash, on 36 resistance trained 
individuals over 28 days. Their results showed no interaction for time and group for the 
following: LBM, fat mass, or body fat percentage (Jagim et al., 2012). Hoffman et al. (2006) 
recruited 33 college aged football players and tested a 10-week intervention of creatine using 
a Dexa scan to test body composition. They found no interaction in any three of their groups: 
placebo, creatine, and creatine plus beta-alanine on the following body composition 
measurements: fat mass, LBM, or body fat percentage. Another acute loading phase of 
creatine study on 23 males found that they had increased fat free mass from 71.2 ± 10 to 72.8 
± 10.1 kg (p<0.001) (Becque et al., 1999). College aged males taking creatine phosphate or 
monohydrate over six weeks showed increased lean body mass accompanied with significant 
increases in maximal upper body strength (Peeters et al., 1999). Subjects taking creatine 
phosphate had an increase of lean body mass of 2.2 ± 1.13% and an increase of 8.83 ± 3.49% 
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for bench press maximal strength. The creatine monohydrate increased their lean body mass 
by 2.67 ± 1.92% and 11.15 ± 5.51% for bench press 1RM.  
 Creatine effects on body water. Increases in muscular creatine storage are usually 
coupled with an increase of intra-cellular water. However, most research shows that any 
change in body fluid volume does not significantly change based on creatine supplementation 
(Francaux et al., 1999). Cellular fluid was analyzed utilizing a BIA unit for compartmental 
water volumes in college aged males following nine weeks of creatine supplementation. 
There were no significant changes in the fluid volume in the intra-cellular or extra-cellular 
compartments for the group supplementing with creatine monohydrate (p>0.05) (Francaux et 
al., 1999). A study examining cell hydration of NCCA Division I football players following 
nine weeks of resistance training and creatine, following a loading then maintenance phases, 
found the contrary. Accompanied with increased LBM, these football players were also 
displayed significantly increased intra-cellular water, following both a loading and 
maintenance phase of creatine supplementation (Bemben et al., 2001). An increase of intra-
cellular water is typically associated with creatine absorption due to the osmotic nature of 
creatine absorption (Brilla et al., 2003).  When creatine is absorbed, water is also taken into 
the cell and increases the total intra-cellular water content.  
 Creatine supplementation may or may not affect both body composition and 
compartmental body water measurements. Changes in either measurement appear to be very 
miniscule when compared to subjects taking a placebo while on the same training regime 
over a short period of time, typically around four to eight weeks (Bemben et al., 2001). This 
effect could be related to creatine responders or non-responders as some individuals are 
unable to absorb extra available creatine. Overall, if any significant changes do appear due to 
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creatine supplementation, they are increases in LBM and slightly increased intra-cellular 
water (Bemben et al., 2001; Becque et al., 1999; Francaux et al., 1999).  
 Potential negative effects of creatine. With an increase of creatine supplementation, 
there has been concern for potential harmful effects (Allen, 2012; Jäger, Purpura, Shao, 
Inoue, & Kreider, 2011; McGuine et al., 2001; Robinson, 2000). Research into the potential 
harmful effects of creatine are directed towards renal dysfunction, creatine concentration, 
muscle damage, and abnormal hepatic function (Jäger et al., 2011; Robinson, 2000). A study 
examined both the acute and chronic effects of creatine and its potential side effects using 
either a loading dose of 20g/day for five days or 3g/day for nine weeks. Researchers took 
blood samples at baseline, end of supplementation, and six weeks post intervention 
(Robinson, 2000). All measures of hepatic function, renal function, and muscle damage were 
within typical healthy ranges. Creatine concentration in the blood samples were increased 
significantly (p<0.05) but were returned to baseline levels following a six week wash out 
period (Robinson, 2000).  
Another study examined the potential negative effects of creatine and found similar 
results (Jäger et al., 2011). The researchers documented that there were no risks for renal 
dysfunction, hepatic dysfunction, or muscle damage while taking creatine supplementation 
for healthy individuals ingesting the supplement. However, it was found that individuals with 
pre-existing renal dysfunction may have an increased risk of worsening their current 
condition.  
Most commonly, with high doses, creatine supplementation results in a greater 
amount of creatine excretion through the urinary tract (Hultman et al., 1996). Thirty-one 
male subjects while ingesting 20g/day for one week of creatine had a significantly increased 
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amount of creatine excretion (p<0.05) accompanied with a 20% increase in muscular 
creatine. There appears to be no increased risk for healthy individuals taking creatine 
supplementation for hepatic or renal function and muscular damage (Jäger et al., 2011; 
Robinson, 2000).  
 Effects of creatine on strength performance. The most common performance 
aspect that is associated with creatine supplementation is maximal strength (Burke et al. 
2003; Bemben et al. 2010; Herda et al. 2009; Vandenberghe et al. 1997). Increased PCr is 
greatly associated with performance that is intermittent and only lasting ten seconds.  
Maximal strength testing is calculated through either a single repetition maximum test or 
other testing using a three to five repetition maximum, making it the perfect candidate for 
enhancement with creatine supplementation (Antonio & Ciccone, 2013Herda et al. 2009).  
 Upper body strength increases were found in older populations when supplementing 
with 5g/day for six weeks. There was a significant (p<0.0001) increase of chest press 
strength from 24.1 ± 3.2 to 40.5 ± 6.8 kg (Tarnopolsky et al., 2009).  
Another study examined the acute supplementation effects on participant’s bench 
press 1RM for bench press (Zuniga et al., 2012). Subjects were given 20g/day for seven days 
and were tested for their absolute 1RM at baseline and post supplementation. The researchers 
found no significant increases in bench press maximal strength following their acute 
intervention. 
An eight-week intervention study examined the effect of rest time intervals in 
individuals on their maximal bench press strength (Souza-Junior et al., 20110). Subjects were 
given creatine monohydrate at maintenance dose levels for eight weeks while performing 
resistance training. One group maintained a consistent rest time interval with the second 
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group decreasing rest intervals 15 seconds per week (Souza-Junior et al., 2011). The constant 
interval of rest increased their bench press 1RM from 102 ± 10 kg to 130 ± 10 kg with a large 
effect size. The decreasing rest interval group increased their bench press 1RM from 100 ± 
12 kg to 125 ± 12 kg with a large effect size. There was no significant (p<0.05) interaction 
between groups, displaying that rest intervals played little role in their strength increases.  
Another study examined creatine supplementation compared to betaine on maximal 
bench press strength using untrained individuals (del Favero et al., 2012). Subjects in the 
creatine groups were given 20g/day and were tested for their bench press 1RM at baseline 
and following the intervention. Groups that were supplementing with creatine monohydrate 
had a significantly increased (p<0.027) bench press from baseline to post-test. Subjects had 
an approximate increase of 5% on their bench press 1RM when compared to their baseline 
values.   
 While using creatine supplementation, lower body maximal strength increases vary 
more when compared to upper body strength. College age lacrosse female players did not 
show any significant effects from a five-week creatine intervention when tested for maximal 
leg extension strength (Brenner et al., 2000). However, middle-aged men using creatine 
coupled with resistance training did have increased 1RM strength for the leg curl and leg 
extension (Bemben et al., 2010). The leg curl and leg extension were also part of the 
resistance training periodization exclusively done for lower limb exercises during the five 
weeks. Leg press increased following an intervention of creatine and resistance training in 
healthy individuals (Herda et al., 2009; Pearson, Hambox Wade Russel, & Harris, 1999; 
Tarnopolsky et al., 2007). Herda et al. (2009) observed an eight percent increase in leg press 
1RM following a 30 day creatine intervention. Creatine supplementation does appear to have 
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an effect on maximal lower limb strength, mostly dealing with exercises that are controlled 
using machines.  
 Creatine supplementation aids in both the upper body and lower body maximal 
strength. These studies utilized both large and small dosages to yield similar results (Bemben 
et al., 2010; Herda et al., 2009; Tarnopolsky et al., 2007). Creatine coupled with resistance 
training is beneficial in enhancing the strength performance in both the upper and lower 
extremities.  
 Creatine effects on power. Most athletic performances require a great deal of work 
to be produced in a short amount of time. Sprinting and jumping are two common tasks that 
require power to be performed at a higher level. Researchers to reach the maximal potential 
of peak power for such performances have examined the effect of creatine. The Wingate test 
and counter movement jump test are the two most common testing techniques for lower 
extremity power output for creatine supplementation research (Claudino et al., 2014; 
Hoffman et al., 2006; Wiroth et al., 2001).  
 Short duration high intensity cycling has been used to evaluate anaerobic power, 
primarily named the Wingate test (Herda et al., 2009; Wiroth et al., 2001). A study involving 
54 healthy men tested power using 30-second Wingate tests after creatine supplementation 
(Herda et al., 2009). After the supplementation period, there were no significant differences 
found in either peak or mean power in subjects supplementing with creatine. Researchers 
suggested that could be a possibility due to the CP system being depleted prior to the 
completion of the test and primarily rely on glycolysis for ATP generation.  
A similar study examining the effects of creatine in older participants compared old 
and young volunteers using five all-out ten second cycling sprints for power and total work 
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done (Wiroth et al., 2001). Subjects were separated into three different groups: sedentary old, 
trained old and sedentary young. Subjects were supplemented with 15g/day doses for a total 
of five days. Elderly and young sedentary men displayed increases in maximal power, 3.7% 
and 2.0% respectively (p<0.05). The trained elderly old males did not exhibit any creatine 
effect from pre-test to post-test.  
 Another power test is done with countermovement jumps on a force platform 
(Hoffman et al., 2006). A study involving college football players used a 20 akimbo 
countermovement jump test to examine peak power differences based on ten weeks of 
creatine supplementation (Hoffman et al., 2006). The group with creatine did not differ 
significantly from pretest to posttest, 62.6 ± 13.8 to 62.7 ± 10.1 watts (Hoffman et al., 2006).  
Claudino et al. (2014) conducted a study using 14 professional Brazilian soccer 
players testing for lower limb power using a countermovement jump. Supplementation lasted 
seven weeks and there were no significant differences in power, but there was a trend to 
increased power compared to placebo, 2.4% versus 0.7% respectively. Creatine 
supplementation could possibly be used to increase the power demonstrated in 
countermovement jumps.  
 Creatine effects on work. Along with strength and power, creatine has been used to 
increase the work capacity for various exercises and performances (Brenner et al., 2000; 
Herda et al., 2009; Kreider et al., 1997; Vincent et al., 1998). The performances range from 
increasing 40 yard dash time, maximal repetitions of bench press, maximal repetitions of 
back squat, total volume for lifting, and power clean maximum load. A study examining the 
effect of creatine on cycling work, examined both older and young people after creatine 
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supplementation. Total work during a cycling task was increased, not significantly, in older 
and young people using creatine, 4.1% and 5.1% (Wiroth et al., 2001).  
 A study reviewing the effects of creatine monohydrate on college males tested their 
40 yard dash time pretest and posttest after a loading phase, 5g/day, and varying maintenance 
phases, 100 mg/kg/day or 300 mg/kg/day (Noonan et al., 1998). The group supplementing 
with creatine at 100 mg/kg/day had significantly (p<0.05) increased 40 yard dash time 
compared to both the placebo and 300 mg/kg/day groups (Noonan et al., 1998). Researchers 
hypothesized that the higher creatine dosage did not correlate to a higher creatine absorption 
and was above the recommended dose for performance benefits.  
A study examining 28 days of creatine supplementation on 18 power lifters tested the 
maximal number of repetitions done on bench press across five sets using 80% 1RM 
(Vincent et al., 1998). The creatine group had increased number of bench press repetitions 
for sets 1, 4, and 5 compared to the placebo group. Overall, there was an increase of 39.7% ± 
23.5 % of repetitions for the creatine supplementation group (Vincent et al., 1998).   
Herda et al. (2009) used a similar protocol for a single set of bench press to failure 
using 80% of subject’s 1RM. Fifty-four healthy men were used in the study examining 
creatine monohydrate and polyethylene glycosylated creatine compared to a placebo. All 
groups in the study displayed an increase for the number of repetitions performed until 
failure at 80% 1RM (Herda et al., 2009). The creatine supplementation group had a 20% 
increase in the number of repetitions to failure during their bench press repetition test.  
Another study tested the total work done during maximal repetition tests for both 
bench press and leg press after female lacrosse players were supplemented with creatine. The 
creatine group was given 20g/day for one-week followed by 2g/day for the remaining four-
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weeks. Their results displayed no differences for work done comparing the experimental and 
placebo group, 283.5 ± 387.3 watts (Brenner et al., 2000). Research findings vary on the 
accounts for total work performed being enhanced after creatine supplementation (Brenner et 
al., 2000; Vincent et al., 1998). An increase of repetitions at a specified load correlates to a 
greater amount of work being performed.  
Summary 
 Creatine supplementation plays a key role for increasing the performance through 
increasing the work capacity by the CP system. Supplementing orally on a daily basis with 
creatine increases the amount of muscle creatine concentration while supporting a faster 
resynthesize of PCr (Greenhaff et al., 1994). Doses of creatine do not dramatically change 
the benefits or risks of creatine use (Allen, 2012; Hultman et al., 1996; Jäger et al., 2011; 
Robinson, 2000). Increased doses of creatine primarily increase muscular creatine at a faster 
rate, and also increase creatine excretion (Greenhaff et al., 1996; Hultman et al., 1996). 
During supplementation, some studies find that both body composition and body water 
analysis do not vary when compared to placebo groups (Kresta et al., 2014; Jagim et al., 
2012). Some research studies have observed increases in intra-cellular water indicating 
creatine absorption (Brilla et al., 2003) Some small changes in lean body mass may be 
observed when creatine is used with resistance training (Jagim et al., 2012).  
 Upper body strength, typically a 1RM bench press, is significantly increased when 
using creatine at varying doses with resistance training (del Favero et al., 2012; Souza-Junior 
et al., 2011; Zuniga et al., 2012). Lower body strength may also be improved with a creatine 
intervention (Candow, Chilibeck, Burke, Mueller, & Lewis, 2011; Bemben et al., 2010; 
Brenner et al., 2000; Larson-Meyer et al., 2000). Creatine appears to have little effect on 
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power when using 30 second Wingate cycling test and countermovement jump protocols 
(Herda et al., 2009; Hoffman et al., 2006; Wiroth et al., 2001). However, this may be due to 
the protocol used and the importance of the CP system in those protocols. Protocols using 
cycling tests lasting longer than 15 seconds displayed no significant effect of creatine 
supplementation. Other key factors for performance have been increased with using creatine 
supplementation including: 40 yard dash times, repetitions to failure, repetitions to failure per 
set, as well as total work done (Brenner et al., 2000; Cooper et al., 2013; Kreider et al., 1997; 
Vincent et al., 1998).  
 The use of creatine has a potential effect on power, strength, and amount of work for 
people post supplementation (del Favero et al., 2012; Herda et al., 2009; Vincent et al., 
1998). However, the majority of research does not examine the effects of creatine formulated 
alongside electrolytes, a primary form of cell transportation for creatine (Allen, 2012). The 
current study aims to examine the efficacy of a creatine supplement with electrolytes (Barber 
et al., 2013; Brilla et al., 2003). This study aims to further examine the effects of a creatine 
supplementation formulated with several electrolytes over a longer period of time. Few 
studies have examined maximal strength, work, power, and mRFD for common exercises 
such as the back squat and bench press.   
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Chapter III 
Methods 
Introduction 
 The current study examined the effects of a multi-ingredient performance supplement 
(MIPS) on: mean and peak power during an akimbo countermovement jump, one-repetition 
maximum (1RM) bench press, 1RM back squat, and the concentric work, mean power, peak 
power, peak force, and mean rate of force development of a maximal repetition set of back 
squat and bench press at 80% 1RM.  Additionally the study examined the MIPS effect on % 
body fat, lean body mass, fat mass, total body water, intra-cellular water, and extra-cellular 
water. Creatine supplementation is a very common intervention to enhance athletic 
performance for both strength and power activities ranging from 1RM strength, power during 
countermovement jumps, and total work capacity (Kreider et al., 1997; Vincent et al., 1998). 
Few studies examine the potential benefits of combining creatine with electrolytes to enhance 
the supplementation effect due to increased availability of cell transporters.  
Description of study population 
 A total of 22 subjects, 16 males and six females, aged 18-35 were included for this 
study. All subjects were regularly strength training for a minimum of six months prior to the 
study, free of any injury that would inhibit training, creatine supplementation-free for at least 
one month prior to participation, and free from any endocrine/kidney disease that would 
impact their clearance of creatine. Subjects were divided into two groups, the experimental 
MIPS group (n=12, male=8, female=4) and the placebo group (n=10, male=8, female=2).   
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Design of the study 
 This study utilized a double blind, randomized, pre- and post-test repeated measures 
design to examine the effect of a multi-ingredient supplement on strength and power 
performance. Subjects were recruited locally from Western Washington University and the 
surrounding Bellingham area. Subjects were randomly assigned to either the experimental 
MIPS group or placebo group prior to their arrival for testing. A total of six weeks 
supplementation was completed between pre-test and post-test measurements to ensure tissue 
saturation to display the possible effects of the intervention.   
Data collection procedures 
Instrumentation. Subjects’ height weas recorded using a stadiometer and weight was 
measured using the BodPod weighing scale (COSMED, Rome, Italy). Body composition was 
determined using a BodPod air displacement plethysmography system (COSMED, Rome, 
Italy). Total, extracellular, and intracellular water were obtained using the resistance and 
reactance from a Quantum X bioelectrical impedance unit (RJL Systems, Clinton, MI, USA) 
input into the manufacturer’s online calculator. An AMTI triaxial force platform (AMTI, 
Watertown, MA, USA) was used to measure the amount of vertical force applied during the 
akimbo counter movement jump. Data from the force platform was exported into Bioanalysis 
software version 2.3.1 (AMTI, Watertown, MA, USA) for data processing.  A standard 
barbell squat rack (PR Lifting, Everett, WA, USA) was used to accommodate the 
performance of the back squat and bench press in the laboratory setting. The barbell 
trajectory was collected using Qualisys Track Manager 2.7 (Qualisys Motion Capture 
Systems, Gothenburg, Sweden) and seven Qualisys Proreflex MCU 240 cameras (Qualisys 
Motion Capture Systems, Gothenburg, Sweden) during the back squat and bench press 
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exercises performed at 80% 1RM for maximal repetitions. Data processing was completed 
using custom-written LabView version 13.0 (National Instruments, Austin, TX, USA) 
software for both the akimbo countermovement jump and the concentric back squat and 
bench press performance tests at 80% 1RM.  
 BodPod. Air displacement was determined using a BodPod (COSMED, 
Rome, Italy). Using subject information, a two dimensional model can be made on the body 
composition of the subjects. The two compartment model includes lean body mass (LBM) 
and fat mass (FM). The BodPod was calibrated daily for collection using the standard 
procedure and standardized volume containers. Subjects wore the same clothing for both 
testing dates to ensure the consistency of the measurements.  
 Bioelectrical Impedance. Measurements of total body, extra-cellular, and 
intra-cellular water were determined using the resistance and reactance values obtained from 
a Quantum X bioelectrical impedance unit (RJL Systems, Clinton, MI, USA) utilizing 
Ac/Agl surface electrodes placed on the following landmarks: inferior to the  ulnar styloid 
process, inferior of the third metacarpal, directly between the malleoli, and distal to the third 
metatarsal. Subjects were asked to remain hydrated and refrain from strenuous exercise the 
day prior to the body water analysis.  
 AMTI Force Platform. An AMTI OR6-6 in-ground force platform and 
MSA-6 amplifier (AMTI, Watertown, MA, USA) was used to collect ground reaction force 
data during the akimbo countermovement jump. The data acquisition rate was set to 50 Hz 
and kept consistent for every subject.  
  Qualisys Motion Capture. Qualisys motion analysis system (Qualisys 
Motion Capture Systems, Gothenburg, Sweden), using 7 ProReflex cameras at 240 Hz were 
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utilized to collect kinematic data of the barbell position throughout the range of motion of 
both the bench press and back squat exercises performed for maximum number of repetitions 
at 80% 1RM. One passive retro-reflective marker was placed in the center of the barbell at 
the end. This marker was used to determine the vertical position of the bar throughout the 
time of testing. Time elapsed, vertical displacement, and force were calculated to determine 
the outcome measures for the maximal repetition tests.   
 Measurement Techniques and Testing Procedures.  
 All testing procedures were conducted on the Western Washington University 
campus in the Exercise Physiology and Applied Neuromechanics laboratories. Subjects were 
given an informed consent form (Appendix A) and a hold harmless agreement (Appendix B) 
upon their arrival to their pre-testing session. Subjects were given the opportunity to ask any 
clarifying questions about the informed consent or hold harmless agreement, and then signed 
the forms. All subjects were given a copy of the informed consent for their own files. 
Afterwards, subjects completed a general background information form for the subject files 
(Appendix C). Subjects were also asked to fill out a background information form and to 
confirm their eligibility for the study Subjects had their height and weight measured prior to 
data collection.  
BodPod. Following their completion of the appropriate paper work, subjects were 
asked to change into clothing as close to spandex as possible, and fitted with a swim cap. 
Attire was asked to be kept similar for post-testing to minimize error with air pockets. 
Subjects were asked to stand quietly on the scale to obtain their weight for the BodPod 
measurement. Following the calibration, subjects were asked to sit quietly while the BodPod 
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measured their air displacement for body composition measurements. A minimum of two 
trials were used only requiring a third trial if the first two measurements varied too greatly.  
Body Water Analysis. After the BodPod measurements were completed, subjects were 
asked to lie down supine on a table with their limbs completely supported for the BIA 
testing. Four Ag/AgCl surface electrodes were placed on the following land marks on the 
subject’s right side: styloid process of the Ulna, base of the third metacarpal, between 
malleoli, and the base of the second metatarsal. The BIA wires were connected to the 
electrodes to measure the resistance (ohms) and reactance (ohms). The resistance and 
reactance were then entered into RJL systems (RJL Systems, Clinton, MI, USA) online 
calculator to provide the subject’s total, extracellular, and intracellular water. Following the 
BIA measurement, subjects changed into their athletic clothing and walked to the Applied 
Neuromechanics laboratory for the akimbo countermovement jump, the back squat, and 
bench press testing.  
Warm Up. When the subjects arrived at the WWU Applied Neuromechanics 
Laboratory, they began with a five-minute warm up on a cycle ergometer (Star Trac, Orange 
County, California, USA). Subjects were able to choose their own pace and resistance. 
Following the cycle ergometer warm up, subjects performed a dynamic warm-up consisting 
of five repetitions of the following: knee hugs bilaterally, Frankenstein’s bilaterally, walking 
quadriceps stretch bilaterally, lunge with a torso twist bilaterally, wall slides, shoulder slaps 
bilaterally, and push-ups. Upon completion, subjects were given a three-minute self-selected 
rest while researchers explained the akimbo countermovement jump protocol. 
Countermovement Jump. Subjects were asked to stand in the center of the force 
platform with the entirety of both feet inside the square and their hands resting on their hips 
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(Figure 3). Researchers gave subjects a countdown of “1, 2, 3, Jump” to initiate the akimbo 
countermovement jump. Subjects were told to begin their jump after the word “jump” was 
said with collection beginning on “3” in the countdown. Subjects were given two practice 
trials to gain familiarly with the protocol and countdown. Following their practice trials, 
subjects performed three akimbo countermovement jumps separated by one minute of self-
selected rest. After the third trial was completed, subjects were given a four-minute self-
selected rest period while the squat rack was set up for the back squat 1RM test.  
One Repetition Maximum Testing. Subjects watched a pre-recorded video detailing 
how to perform the back squat exercise made by the Graduate Assistant in charge of Strength 
and Conditioning at WWU. The testing for both the back squat and bench press followed the 
National Strength and Conditioning Association guidelines (Souza-Junior et al., 2011). 
Subjects estimated their current 1RM for the back squat based on their previous strength 
training programming. This estimation was used for the loading during the 1RM test, with a 
new 1RM being calculated using the following equation: (1RM = load*(1 + (0.025*number 
of repetitions)). Subjects then performed ten back squat repetitions at 50% of their predicted 
1RM. Subjects were given a four-minute self-selected rest period while the next load was 
prepared, which was 75% of their predicted 1RM. Subjects performed a total of five 
repetitions at their second load followed by for minutes of self-selected rest. Following the 
final rest period, subjects performed as many repetitions as possible at their predicted 1RM. 
Subjects were told to go until failure or until they decided they could not continue. Subjects 
were given a four-minute rest period before moving on to the bench press 1RM test.  
 Subjects were given a pre-recorded video of how to perform the bench press exercise 
made by the Graduate Assistant in charge of Strength and Conditioning at WWU. Subjects 
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were asked to estimate their current one repetition maximum for the bench press based on 
their previous strength training programming. The subject’s current estimation was used for 
prescribing the loading during the 1RM test to estimate their current 1RM using the 
O’Conner formula. Subjects then performed ten bench press repetitions at 50% of their 
predicted 1RM. Subjects were given a four minute self-selected rest period while the next 
load was prepared, which was 75% of their predicted 1RM. Subjects performed a total of five 
repetitions at their second load followed by for minutes of self-selected rest. Following the 
final rest period, subjects performed as many repetitions as possible at their predicted 1RM. 
Subjects were told to go until failure or until they decided they could not continue. Once the 
test was concluded, subjects were given an eight-minute self-selected rest period. Subject’s 
1RM for the back squat and bench press were calculated using the O’Connor formula: (1RM 
= load*(1 + (0.025*number of repetitions)) and used to determine the 80% load for the 
maximal repetition test.  
 Maximal Repetition Testing. When 80% of the subject’s 1RM bench press was 
determined, the load was adjusted on the barbell and placed inside the capture area of the 
Qualisys Motion Capture system. One retro-reflective marker was placed on the end of the 
barbell to track the position of the barbell path. Subjects were instructed to perform as many 
repetitions as possible and to perform them as forcefully as possible. Data collection occurred 
when the subject removed the weight from the rack prior to initiating their first repetition. 
Subjects performed as many bench press repetitions as possible and returned the barbell to its 
resting position. The range of motion given to subjects was set to start at full elbow extension 
with the low point being just above their chest. Subjects were given another eight-minute 
self-selected rest while researchers adjusted the capture area to perform the back squat 
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maximal repetition test. Eighty percent of the subject’s calculated back squat 1RM was used 
for the loading parameters. Data was collected using the Qualisys Motion Capture system 
similarly to the maximal bench press test. Subjects were told to perform their maximal 
number of repetitions as forcefully as possible. The back squat range of motion was set to 
start in the upright position and go until their hips were parallel to their knee. When testing 
concluded, subjects received a quick briefing of the supplementation period and their 
requirements.  
 Subjects were required to pick up supplements weekly in small individual dosages 
from either the Western Washington University Exercise Physiology or Applied 
Neuromechanic Laboratory. Supplementation continued for a total of six weeks with subjects 
taking one dose per day with 16 oz of water accompanied with a meal. The MIPS was 
formulated with the following: 4g of creatine, 857 mg of phosphorus, 286 mg of magnesium, 
171 mg of calcium, 171 mg of potassium, and 114 mg of sodium. The placebo group 
received maltodextrin in a similar package. Orange Crush powder was provided for flavor at 
the subjects own discretion. Following the six weeks of supplementation, subjects returned to 
perform post-testing measurements. Post-testing procedures were kept similar except for the 
load utilized for the maximal repetition test, which used 80% of pre-testing 1RM. The load 
was kept similar from pre-testing when performing the maximal back squat and bench press 
testing to make comparison between the two time points.  
Data Processing 
 Body composition data was exported from the BodPod computer into the final excel 
data file kept on a password-protected university computer. Data values for body fat 
percentage, lean body mass (kg), and fat mass (kg) were recorded. Bioelectrical Impedance 
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values were derived from the resistance (ohms) and reactance (ohms) when imported into the 
manufacturer’s website (RJL Systems, Clinton, MI, USA). Data values for total body water 
(L), extra-cellular water (L), and intra-cellular water (L) were exported into the final excel 
data file. The akimbo countermovement jump data file was exported into Bioanalysis 
software (AMTI, Watertown, MA, USA) and converted into text files. Text files were then 
processed in a custom-made LabView (National Instruments, Austin, TX, USA) program to 
determine mean power (watts), and average peak power (watts) of the three trials collected. 
Mean power was obtained using the following linear regression equation: [Mean Power = 
Jump Height (m) * 21.2 + (Weight (kg) *23) – 1,343] while peak power was obtained using 
the following regression equation: [Peak Power = Jump Height (m) * 61.9 + (Weight (kg) * 
36) + 1,822]. Data were then copied into the final excel data file for statistical analysis. One-
repetition maximum data were collected and determined using an excel template utilizing 
90% of their current estimate repetitions completed until failure. Data values were recorded 
into the final excel file for statistical analysis. The retroreflective marker for the maximal 
repetition tests was identified in Qualisys Motion Tracker (Qualisys Motion Capture 
Systems, Gothenburg, Sweden) and exported into a C3D file format. The C3D file was then 
opened using Visual3D (C-Motion, Germantown, MD, USA) and processed using a custom 
pipeline that performed a 4th order? low pass Butterworth filter before the vertical position 
data (Z coordinate) was exported into a text file. The text files were analyzed in a custom 
Labview (National Instruments, Austin, TX, USA) program that identified the concentric 
phases of completed repetitions before computing the total work, mean power, peak power, 
mean rate of force development, and peak force. Once the concentric phase of movement was 
determined, the program took the sum of (force * displacement) for each repetition to obtain 
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the sum of concentric work. Mean power was obtained by averaging the product of force * 
velocity at each time point during the repetition and set. Similarily, peak power was obtained 
from finding the maximal product of force and velocity during each repetition, with the 
greatest value being used for data analysis. The outcome measurements were copied into the 
excel data file for further statistical analysis.  
Data Analysis 
 Data for the akimbo countermovement jump and maximal repetition tests at 80% 
1RM was exported into text files and then processed using Labview (National Instruments, 
Austin, TX, USA) programs for data computation. Data for the 1RM tests, body composition, 
and body water analysis were directly entered into an excel file. Data were analyzed between 
the experimental MIPS supplement group and the placebo group at pre-test and post-test. A 
two-way mixed analysis of variance (ANOVA) were run with an alpha level of 0.05. The 
independent variables were group (MIPS vs. placebo) and time (pre-test vs. post-test). The 
dependent variables were time in flight, mean power, and peak power for the akimbo 
countermovement jump and total work, mean rate of force development, mean power, peak 
power, and peak force for the concentric phases of the back squat and bench press at 80% 
predicted 1RM for maximal repetitions. A two-way mixed analysis of variance (ANOVA) 
was also run with an alpha level of 0.05 to compare the effects of condition and time on the 
following: percentage body fat, lean body mass, fat mass, total body water, intra-cellular 
water, extra-cellular water, mean and peak power during an akimbo countermovement jump, 
back squat 1RM, bench press 1RM, and concentric work, mean power, peak power, mRFD, 
and peak force during a maximal repetition test done at 80% 1RM for back squat and bench 
press.  
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  Chapter IV 
Results and Discussion 
Introduction 
 This study examined the effects of a six-week supplementation of a multi-ingredient 
performance supplement (MIPS) on body composition, body water, power, and strength. The 
experimental hypothesis was that the group that supplemented with the MIPS would display 
greater: intra-cellular water, lean body mass, peak and mean power during an akimbo counter 
movement jump, one repetition maximum (1RM) strength for both back squat and bench 
press, and total work, mean power, peak power, mean rate of force development (mRFD), 
and peak force during a maximal repetition test at 80% 1RM back squat and bench press.  
Data was collected at two time points, just prior to supplementation and immediately 
thereafter. A two way-mixed analysis of variance (ANOVA) was run with an alpha level of 
0.05 for data analysis. 
Results 
 Demographics. Age, sex, height, and weight were all recorded at pre-test and post-
test to describe the samples for both the placebo and MIPS groups (Table 1). No statistics 
were run on the demographics data. The placebo group had a decrease of mass from 73.10 to 
72.97 kg. The MIPS groups had a decrease of mass from 71.82 to 71.55 kg.  
 
Table 1. Demographical Data (mean ± SD) 
  Placebo  MIPS 
 Pre-Test  Post-Test Pre-Test  Post-Test 
Age (yr) 20.70 ± 1.49  20.7 ± 1.49 21.92 ± 2.71  21.92 ± 2.71 
Height (m) 1.74 ± 0.11  1.74 ± 0.11 1.70 ± 0.08  1.70 ± 0.08 
Mass (kg) 73.10 ± 13.56  72.97 ± 14.26 71.82 ± 8.84  71.55 ± 6.48 
Sex 8 males / 2 females 8 males / 4 females 
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 Body Composition. Means and standard deviations for % body fat, lean body mass, 
and fat mass are displayed in Table 2. There was no interaction between time and group on % 
of body fat (F[1,19]= 1.998, p = 0.174, η2 = 0.095). There was no main effect of time on % 
body fat (F[1,19]= 0.725, p = 0.405, η2 = 0.037). There was no main effect of group observed 
on % body fat (F[1,19]= 0.061, p = 0.808, η2 = 0.003). No interaction between time and 
group was displayed on lean body mass (F[1,19]= 0.047, p = 0.831, η2 = 0.002). There was a 
significant main effect of time on lean body mass (F[1,19]= 4.633, p = 0.044, η2 = 0.196). 
Both placebo and MIPS group elicited increases in their lean body mass after the six-week 
intervention, 2% and 1.7% respectively (Figure 1). There was no main effect of group on 
lean body mass (F[1,19]= 0.287, p = 0.598, η2 = 0.015). There was no interaction observed 
between time and group for fat mass (F[1,19]= 2.591, p = 0.124, η2 = 0.120). There was no 
main effect of time (F[1,19]= 0.463, p = 0.504, η2 = 0.024) or group (F[1,19]= 0.040, p = 
0.844, η2 = 0.002) on fat mass.  
 
Table 2. Body Composition Results (mean ± SD) 
 Placebo MIPS 
 Pre-Test Post-Test Pre-Test  Post-Test 
Body Fat (%) 15.41 ± 8.24 13.72 ± 6.95 15.11 ± 7.49  15.53 ± 5.97 
Lean Body Mass (Kg) 62.06 ± 13.82 63.30 ± 14.97* 59.51 ± 8.22 60.52 ± 7.53* 
Fat Mass (Kg) 11.04 ± 5.72 9.67 ± 4.44 10.48 ± 4.98 11.03 ± 3.99 
*p<0.05 
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Figure 1. Lean body mass (mean ± SD) 
 
 Body Water Analysis. Means and standard deviations for total body water, intra-
cellular water, and extra-cellular water are presented in Table 3. There was no interaction 
between group and time for total body water (F[1,18]= 0.039, p = 0.845, η2 = 0.002).There 
was no main effect of time on total body water (F[1,18]= 0.011, p = 0.917, η2 = 0.001). There 
was no main effect of group on total body water (F[1,18]= 1.239, p = 0.280, η2 = 0.064). 
There was no interaction between time and group on intra-cellular water (F[1,18]= 0.003, p = 
0.956, η2 = 0.00). There was no main effect of time on intra-cellular water (F[1,18]= 0.070, p 
= 0.794, η2 = 0.004). There was no main effect of group on intra-cellular water (F[1,18]= 
1.133, p = 0.301, η2 = 0.059). There was no observed interaction between time and group on 
extra-cellular water (F[1,18]= 0.181, p = 0.676, η2 = 0.010).There was no main effect of time 
on exra-cellular water (F[1,18]= 0.002, p = 0.967, η2 = 0.00). There was no main effect of 
group on extra-cellular water (F[1,18]= 1.276, p = 0.273, η2 = 0.066).  
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Table 3. Body Water Analysis Results (mean ± SD) 
 Placebo MIPS 
 Pre-Test Post-Test Pre-Test Post-Test 
Total Body Water (L) 43.31 ± 9.10 43.22 ± 8.64 39.50 ± 6.24 39.53 ± 6.26 
Intra-Cellular Water (L) 25.04 ± 5.34 24.99 ± 5.05 22.75 ± 4.41 22.72 ± 4.42 
Extra-Cellular Water 
(L) 
18.27 ± 3.85 18.21 ± 3.67 16.75 ± 2.00 16.79 ± 1.94 
  
Akimbo Countermovement Jump. Results for mean and standard deviation are 
displayed below in Table 4. There was no interaction between time and group observed for 
peak power (F[3,16]= .724, p = 0.406, η2 = 0.039). There was no main effect of time on peak 
power (F[3,16]= 2.756, p = 0.114, η2 = 0.133). There was no main effect of group on peak 
power (F[3,16]= 934, p = 0.347, η2 = 0.049). There was no interaction between time and 
group observed for mean power (F[3,16]= 2.103, p = 0.164, η2 = 0.105). There was no main 
effect of time on mean power (F[3,16]= 1.408, p = 0.251, η2 = 0.073). No main effect of 
group was observed for mean power (F[3,16]= 908, p = 0.353, η2 = 0.048).  
 
Table 4. Akimbo countermovement jump results (mean ± SD) 
 Placebo MIPS 
 Pre-Test Post-Test Pre-Test Post-Test 
Mean Peak 
Power (W) 
6,506.0 ± 848.9 6,635.8 ± 833.8 6,235.9 ± 583.1 6,277.7 ± 676.1 
Mean Power 
(W) 
1,009.9 ± 402.0 1,054.3 ± 396.7 896.3 ± 242.6 891.9 ± 254.0 
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One Repetition Maximum Strength Testing. Maximum strength means and 
standard deviations are displayed below (Table 5). There was a significant interaction 
between time and group for back squat 1RM (F[2,19]= 4.944, p = 0.038, η2 = 0.198). There 
was a main effect of time for the back squat 1RM (F[2,19]= 4.572, p = 0.045, η2 = 0.186). 
There was no main effect of group on back squat 1RM (F[2,19]= 0.419, p = 0.525, η2 = 
0.021). The MIPS group increased their back squat 1RM significantly from 95.1 ± 32.7 kg to 
107.8 ± 39.3 kg following six weeks of supplementation (Figure 2). There was a significant 
interaction between time and group for the bench press 1RM (F[2,19]= 5.565, p = 0.045, η2 = 
0.218). There was a main effect of time on bench press 1RM (F[2,19]= 9.597, p = 0.006, η2 = 
0.324). There was no main effect of group on the bench press 1RM (F[2,19]= 882, p = 
0.0359, η2 = 0.042). The MIPS group displayed a significant increase from 69.2 ± 28.3 kg to 
73.3 ± 30.7 kg following the intervention (Figure 3).  
 
Table 5. One-repetition maximum results (mean ± SD)  
 Placebo MIPS 
 Pre-Test Post-Test Pre-Test Post-Test 
Back Squat 
1RM (kg) 
106.0 ± 44.5 105.8 ± 42.5 95.1 ± 32.7* 107.8 ± 39.3* 
Bench Press 
1RM (kg) 
84.3 ± 34.6 84.9 ± 36.1 69.2 ± 28.3* 73.3 ± 30.7* 
*p<0.05 
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Figure 2. Back squat 1RM (mean ± SD)  
 
Figure 3. Bench press 1RM (mean ±  SD)  
  
 Back Squat Maximal Repetition Test. Results for sum of concentric work, mRFD, 
mean power, peak power, and peak force are displayed below (Table 6). There was no 
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interaction between time and group for the sum of concentric work (F[1,14]= 0.762, p = 
0.397, η2 = 0.052). There was no main effect of time (F[1,14]= 0.749, p = 0.401, η2 = 0.051) 
or group (F[1,14]= 0.707, p = 0.415, η2 = 0.048) for the sum of concentric work. There was 
no interaction of time and group on mRFD (F[1,14]= 0.717, p = 0.412, η2 = 0.049). There 
was no main effect of time (F[1,14]= 0.780, p = 0.392, η2 = 0.053) or group (F[1,14]= 0.769, 
p = 0.395, η2 = 0.052) on mean rate of force development. There was no interaction between 
time and group on mean power (F[1,14]= 0.809, p = 0.384, η2 = 0.055). There was no main 
effect of time (F[1,14]= 0.809, p = 0.384, η2 = 0.055) or group (F[1,14]= 0.808, p = 0.384, η2 
= 0.055) on mean power. There was no interaction between time and group observed on peak 
power (F[1,14]= 1.821, p = 0.199, η2 = 0.115). There was no main effect of time (F[1,14]= 
1.812, p = 0.200, η2 = 0.115) or group (F[1,14]= 1.805, p = 0.200, η2 = 0.114) on peak power. 
There was no interaction between time and group observed on peak force (F[1,14]= 0.750, p 
= 0.401, η2 = 0.051). There was no main effect of time (F[1,14]= 0.734, p = 0.406, η2 = 
0.050) or group (F[1,14]= 0.744, p = 0.403, η2 = 0.50) on peak force.  
 
Table 6. Maximal back squat repetition test results (mean ± SD) 
 Placebo MIPS 
 Pre-Test Post-Test Pre-Test Post-Test 
Concentric 
Work (J) 
3,547.7 ± 2,385.0 3,122.6 ± 1,437.9 3,351.9 ± 2,436.5 3,556.9 ± 2,066.3 
 mRFD  
(N/s) 
1,850.4 ± 618.3 2,962.0 ± 1,387.1 3,086.9 ± 1,625.6 5,928.1 ± 7,396.0 
 Mean 
Power 
(Watts) 
260.5 ± 144.1 287.1 ± 170.3 292.7 ± 158.6 292.7 ± 184.5 
Peak 
Power 
(Watts) 
2,613.1 ± 1,988.4 2,491.6 ± 1,270.3 2,969.3 ± 1,869.4 2,162.0 ± 1,017.7 
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Peak 
Force (N) 
3,829.3 ± 2,020.0 3,564.3 ± 1,387.9 4,220.7 ± 2,328.4 3,350.9 ± 1,172.2 
 
Bench Press Maximal Repetition Test. Means and standard deviations for bench press are 
displayed below (Table 7). There was a significant interaction between time and group for 
sum of concentric work (F[1,19]= 6.031, p = 0.024, η2 = 0.241). There was no main effect of 
time (F[1,19]= 2.736, p = 0.115, η2 = 0.126) or group (F[1,19]= 0.063, p = 0.805, η2 = 0.003) 
on sum of concentric work. The MIPS group displayed an increased sum of concentric work 
from 1,853.9 ± 829.8 to 2,344.7 ± 1,121.2 J (26%) (Figure 4). There was a significant 
interaction between time and group for mRFD (F[1,19]= 4.397, p = 0.050, η2 = 0.188). There 
was no main effect of time (F[1,19]= 0.942, p = 0.344, η2 = 0.047) or group (F[1,19]= 3.140, 
p = 0.092, η2 = 0.142) on mRFD. The placebo group had a significant decreased mRFD from 
7,293.9 ± 6,240.7 to 5,385.4 ± 5,034.0 N/s (-26%) and the MIPS group had a significant 
increase from 3,620.4 ± 2,358.7 to 4,432.0 ± 3,152.2 N/s (+22.4%) (Figure 5). There was a 
significant interaction between time and group for mean power (F[1,19]= 5.946, p = 0.025, η2 
= 0.238). There was no main effect of time (F[1,19]= 2.136, p = 0.160, η2 = 0.101) or group 
(F[1,19]= 0.714, p = 0.409, η2 = 0.036) on mean power. The MIPS displayed an increased 
mean power from 169.7 ± 73.6 to 200.1 ± 83.0 watts (+17.9%) (Figure 6). There was no 
observed interaction between time and group for peak power (F[1,19]= 0.122, p = 0.731, η2 = 
0.006). There was no main effect of time (F[1,19]= 1.009, p = 0.328, η2 = 0.050) or group 
(F[1,19]= 0.562, p = 0.463, η2 = 0.029) on peak power. There was no interaction between 
time and group on peak force (F[1,19]= 0.535, p = 0.473, η2 = 0.027). There was no main 
effect of time (F[1,19]= 0.355, p = 0.559, η2 = 0.018) or group (F[1,19]= 0.738, p = 0.401, η2 
= 0.037) displayed on peak force.  
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Table 7. Maximal bench press repetitions test (mean ± SD) 
 Placebo MIPS 
 Pre-Test Post-Test Pre-Test Post-Test 
Sum of 
Concentric 
Work (J) 
1,990.6 ± 864.7 1,923.6 ± 703.8 1,853.9 ± 829.8* 2,344.7 ± 1,121.2* 
 Mean Rate of 
Force 
Development 
(N/s) 
7,293.9 ± 6,240.7 5,385.4 ± 5,034.0 3,620.4 ± 2,358.7* 4,432.0 ± 3,152.2* 
 Mean Power 
(Watts) 
197.9 ± 113.6 191.3 ± 110.4 169.7 ± 73.6* 200.1 ± 83.0* 
Peak Power 
(Watts) 
1,204.7 ± 604.0 1,295.8 ± 629.1 1,134.8 ± 679.6 1,275.5 ± 579.8 
Peak Force 
(N) 
2,524.0 ± 1,141.8 2,789.0 ± 1,363.9 2,564.9 ± 1,450.8 2,507.6 ± 1,074.7 
*p<0.05 
 
Figure 4. Bench press total concentric work (J) (mean ± SD)  
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Figure 5. Bench Press mean RFD (N/s) (mean ± SD) 
 
Figure 6. Bench Press mean power (Watts) (mean ± SD)  
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variables for back squat, bench press, countermovement jump, body composition, and body 
water in recreational trained individuals. The results of this study supported the hypothesis 
displaying an increase in back squat maximal strength and bench press maximal strength, 
concentric work, mRFD, and mean power. This study used a maximal repetition test to 
predict a one repetition maximum for both back squat and bench press. There was a 
significant increase in maximal strength (1RM) for both back squat and bench press in the 
MIPS group after the six weeks of supplementation. During a maximal repetition test at 80% 
of subject’s 1RM bench press, subjects displayed a significant increase of average concentric 
work, average mean rate of force development, and average mean power for the MIPS group 
across the repetitions. There were no observed differences for average concentric work, 
average mean rate of force development, average mean power, average peak power, or 
average peak force during the back squat maximal repetition test.  
 There is little to no change for any variable for the akimbo countermovement jumps 
in either group. This could be largely based on the sampling rate being set too low for data 
collection of a countermovement jump. Data collection was set to 50 Hz sampling rate 
compared to the typical 1200 Hz used for countermovement jumps. With such a low 
sampling rate, valuable data could be lost during collections for a movement that occurs in 
one to two seconds.  
 The results of this study demonstrated significant increases for the MIPS group for 
both 1RM back squat of 12.7 kg (95.1 ± 32.7 to 107.8 ± 39.3 kg) and 1RM bench press of 4.1 
kg (69.2 ± 28.3 to 73.3 ± 30.7 kg). The MIPS supplementation group had a significant 
increase over time on maximal strength for both lower and upper body. This same increase 
was not observed in the placebo group. The MIPS group displayed a significant increase in 
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average concentric work of 490.8 J (1,853.9 ± 829.8 to 2,344.7 ± 1,121.2 J, p = 0.024), 
average mean rate of force development (3,620.4 ± 2,358.7 to 4,432.0 ± 3,152.2 J, p = 0.05) 
and average mean power of 30.4 watts (169.7 ± 73.6 to 200.1 ± 83.0 watts, p = 0.025). Based 
on these results, the MIPS supplement was beneficial in enhancing various performance 
characteristics over a six-week time frame. Subjects taking the MIPS exhibited a greater 
increase of work performed following the supplementation period, and were able to reach 
their power at a faster rate demonstrated by the significant increase in their mRFD after six 
weeks of supplementation.  
 Creatine supplementation is used to increase the amount of stored intramuscular 
creatine and phosphocreatine (PCr) for use during short bouts of anaerobic activity (Allen, 
2012; Greenhaff et al., 1994). Creatine supplementation increases the PCr stores as well as 
the re-synthesis in the human body (Greenhaff et al., 1994). PCr has a role in 
phosphorylating ADP into ATP for movement. The use of electrolytes aids in providing 
transporters for creatine from the plasma into the muscles (Allen, 2012; Jäger et al., 2011).  
 Studies employing creatine supplementation for improvement in power output have 
involved lower body activities such as countermovement jumps and Wingate tests to measure 
power (Earnest et al., 1995; Herda et al., 2009; Hoffman et al., 2006). Hoffman et al. (2006) 
collected kinetic data during a total of 20 akimbo countermovement jumps to measure power 
output following 10 weeks of creatine supplementation in college football players. Similar to 
the current study, Hoffman et al. (2006) found no significant change in peak power while 
using creatine monohydrate for 10 weeks (62.6 ± 13.8 to 62.7 ± 10.1 W/kg). Researchers also 
displayed no significant increase in mean power for the creatine groups (52.8 ± 12.1 to 54.8 
± 9.2 W/kg) (Hoffman et al., 2006). The current data indicate similar results, in that both 
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mean and peak power were not significantly affected by a creatine and electrolyte 
supplementation intervention. The results in the current study could have been greatly 
affected by a very low sampling rate of 50 Hz when compared to the standard 1200 Hz 
collection rate. However, Hoffman et al. (2006) used 20 consecutive akimbo 
countermovement jumps instead of three trials of one akimbo countermovement jump. The 
use of 20 akimbo countermovement jumps could affect their results due to the phosphagen 
system being depleted long before the collection was completed.  The study by Hoffman et 
al. (2006) appears to be a study more designed for fatigue rather than raw power output.  
 Creatine supplementation has increased the maximal strength for both the back squat 
and leg press exercises following supplementation (Hoffman et al., 2006; Pearson et al., 
1999; Larson-Meyer et al., 2000). Hoffman et al. (2006) found an increase of about 25 ± 6 kg 
from a baseline of 115.9 ± 17.7 kg, for groups supplemented with creatine for 10 weeks using 
10.5g/day doses. Pearson et al. (1999) also found results that indicated a significant increase 
in back squat 1RM following 10 weeks of creatine supplementation. Subjects were given 
5g/day for the supplementation period and experienced similar results (Pearson et al., 1999). 
Another study tested maximal back squat strength in female soccer players at five and 13 
weeks of creatine supplementation (Larson-Meyer et al., 2000). Supplementation consisted 
of a 15g/day for one-week loading phase followed by a four-week maintenance phase of 
5g/day. The soccer players displayed significant increases in their 1RM back squat at both 
five weeks and 13 weeks intervention compared to their baseline testing (Larson-Meyer et 
al., 2000). These results are very similar to the current data, which showed an increase of 
13.4% following only a six-week MIPS intervention. The literature and current study seem to 
agree that creatine supplementation lasting at least five weeks can increase back squat 
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maximal strength across various populations ranging from recreational to competitive 
athletes. Benefits from the MIPS were also very similar to those using creatine monohydrate 
at relatively similar doses, 4-5 g/day.  
 Along with increases in lower body strength, creatine supplementation has 
significantly increased the upper body maximal strength in a range of people (del Favero et 
al., 2012; Earnest et al., 1995; Hoffman et al., 2006; Souza-Junior et al., 2011; Syrotuik et al., 
2000). Commonly, researchers use a 1RM test of bench press to assess the approximate 
increases in upper body strength following an intervention. Hoffman et al. (2006) found a 2.5 
fold increase in bench press 1RM when comparing creatine to a placebo group following 10 
weeks of supplementation. Another study using 28 days of creatine supplementation found a 
6% increase in bench press 1RM when compared to their baseline values (Earnest et al., 
1995). Pearson et al. (1999) used a 5 g/day creatine supplementation over 10 weeks and 
found that bench press maximal strength significantly increased. A recent study involving 
recreational bodybuilders used 5g/day doses and observed an increase in bench press 1RM 
over a four week period (6.6 ± 8.2 kg to 7.6 ± 6.1 kg) (Antonio & Ciccone, 2013). While 
most studies display a significant increase with bench press 1RM, some recent studies have 
found no significant improvements in creatine supplementation compared to placebo 
counterparts (Souza-Junior et al., 2011; Zuniga et al., 2012). Such studies are examining the 
acute effects of a large loading dose, typically only covering five to seven days rather than 
occurring over weeks. The current study showed results similarly in line with significant 
upper body strength increases using a moderate duration of supplementation, 6 weeks, and 
using maintenance level doses of 4 g/day. This study was able to conclude that MIPS 
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supplementation over six weeks was beneficial for both back squat and bench press maximal 
strength.  
 Very few studies using creatine supplementation have been done using the 
performance variables in the current study, repetitions to failure under certain loading 
conditions (Cooper et al., 2013; Herda et al., 2009; Vincent et al., 1998). With the current 
study examining the total concentric work during the maximal repetition set. A 28-day 
supplementation study using male power lifters examined creatine’s effect on maximal 
repetition tests across five subsequent sets of bench press (Vincent et al., 1998). Following 
supplementation, the groups supplementing with creatine had an increased number of 
repetitions in sets one, four, and five (Vincent et al., 1998). This finding could primarily be 
due to the effect of creatine supplementation increasing PCr based on a repetition test 
occurring at 80% 1RM is heavily dependent on the CP. Other variables could play a role in 
the increase of repetitions including: motor unit recruitment or increased muscle mass. The 
current study only used a single set at 80% of their determined 1RM to closely examine the 
effect of MIPS supplementation on maximal repetitions to failure. A more recent study 
examined a similar protocol of performing repetitions to failure at 80% 1RM (Herda et al., 
2009). Following 30 days of supplementation, all groups in the study had increased amount 
of repetitions when compared to baseline testing. The groups included in the study included a 
creatine monohydrate and creatine polyethylene glycosylated supplements (Herda et al., 
2009). The significant increase of 26.5% in the current study appears to be in line with 
current knowledge of creatine increasing the work capacity until failure while performing the 
bench press exercise at 80% 1RM.  
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Subsequently, the current study found an increase in mRFD and mean power during 
the bench press maximal repetition test. A maximal repetition test at this specified load is 
heavily dependent on the CP system (Vincent et al., 1998). While no research was found on 
mRFD during the bench press, an increase of mRFD shows a possibility of decreased rate of 
fatigue. Subjects that displayed an increased mRFD were achieving their peak power at a 
much faster rate throughout their repetition test. Mean RFD has two major components that 
could be influenced due to fatigue: velocity and force. With an increase in mRFD, it is a 
possibility that it took MIPS participants longer to have a velocity drop off to their peak force 
being applied, displaying a reduced rate of fatigue.  
 There were some limiting factors to the current study that could have influenced the 
results. The maximal repetition strength test was conducted using as many repetitions as 
possible at 80% of their predicted 1RM. Subjects could have given an inaccurate value for 
their current 1RM strength for either bench press or back squat when entering the study, 
potentially decreasing the accuracy of the estimation. Subjects were told to refrain from 
strenuous exercise prior to testing, but this could not be controlled for. The timeframe of 
testing was also a limitation of the study with the back squat maximal repetition test being 
conducted with almost 16 minutes of rest following the back squat 1RM. Subjects may have 
lost their warm up in the lower extremities while performing the bench press exercise. There 
was also no control used for back squat depth for subjects to maintain. Subjects were told to 
squat low enough where their hips were parallel or below their knees (90° knee flexion). 
Finally, due to an equipment error, all force platform data was collected at 50 Hz rather than 
the typical 1200 Hz used for counter movement jumps. With a low capture rate, the data may 
not be accurate.  
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Summary  
 Six weeks of MIPS supplementation can be beneficial for increasing multiple facets 
of athletic performance in recreational trained individuals. The MIPS increased both back 
squat and bench press 1RM strength and an increase in lean body mass. Subsequently, the 
MIPS also displayed increases in the sum of concentric work, average mRFD, and average 
mean power while performing a maximal repetition test of bench press at 80% 1RM load. 
There was no significant difference or effect on the following outcome measures: % body fat, 
fat mass, total body water, intra-cellular water, extra-cellular water, mean or peak power in 
the akimbo countermovement jump, sum of work, mRFD, mean power, peak power, and 
peak for during the back squat, and peak power and force during the bench press. The current 
study appears to be in line with previous research. This MIPS consisting of creatine and 
electrolytes could be beneficial for people wishing to increase their performance.  
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Chapter V 
Summary, Conclusions, and Recommendations 
Summary 
 This study examined the effects of a multi-ingredient performance supplement 
(MIPS) formulated with creatine and electrolytes on body composition, body water, and 
performance during akimbo countermovement jumps, back squat, and bench press. Subjects 
were randomly assigned to either the placebo or experimental group and supplemented for a 
period of six weeks. Subjects were tested at baseline (pre-test) and immediately following 
supplementation (post-test). Testing consisted of body composition tested through air 
displacement plethysmography, body water analysis, an akimbo countermovement jump, 
1RM test for both back squat and bench press, and a maximal repetition test at 80% load for 
both back squat and bench press. Supplementation resulted in a significant increase in both 
the back squat and bench press 1RM tests in the MIPS group. Accompanied with the strength 
increases, there was a significant increase in bench press sum of concentric work, mean rate 
of force development (mRFD), and average mean power. There were no observed differences 
in body composition, body water, akimbo countermovement jump performance, and 
concentric work, mRFD, mean power, peak power, and peak force during the back squat 
repetition test.   
Conclusions 
 The MIPS used in the current study consisting of creatine and electrolytes can be 
beneficial for recreationally training individuals. Specifically, recreationally active people 
can use this MIPS to increase their maximum strength for both upper and lower body 
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exercises such as bench press and back squat. Accompanied with increase strength, is an 
increase performance during a higher repetition sets to failure in the bench press exercise.  
Recommendations 
 Future Research. This current study suggests that both bench press and back squat 
maximal strength can increase with MIPS supplementation. Bench press performance 
increased during a maximal strength test and repetitions to failure test done at 80% 1RM. 
Future research could focus on expanding to more resistance training exercises using similar 
repetitions to failure that rely greatly upon the creatine phosphagen system. Since creatine 
supplementation has been noted to have the greatest effect on repeated bout exercises 
(Cooper et al., 2013; Herda et al., 2009; Vincent et al., 1998). Future research should also 
aim to examine the effects across multiple sets and repetition parameters through fatigue. 
Expanding research to different groups of people would greatly enhance the knowledge 
around the MIPS. Using competitive athletic teams to test the supplementations effect on 
people at a higher level of training. Doing so would also give a more accurate comparison 
since subjects will typically be more uniformed whereas recreationally training status does 
have a wider variation. More research could repeat repetition to failure testing across 
multiple days to allow for appropriate CP system recovery and to add more data for accuracy. 
Researching the effects of the supplementation on rest intervals could be used to gain insight 
of PCr resynthesize and recovery of the CP system compared to standard creatine 
supplementation.  
 Practical Applications. The results presented in the current study indicated that a 
supplement formulated with creatine and electrolytes can improve performance for 
recreationally trained people compared to a placebo. People who are recreationally trained 
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and want to improve strength and bench press performance could take the supplement daily 
and see results in about six weeks. This study was the first to examine a creatine supplement 
formulated with this balance of electrolytes and further research is required to confirm 
benefits.  
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Appendices 
Appendix A: Informed Consent 
Consent to Take Part in a Research Study 
 
Project: Effect of a Multi-ingredient Performance Supplement (MIPS) on Strength 
and Power in Weight-trained Subjects 
 
You are invited to participate in a study investigating the effects of a multi-ingredient 
performance supplement (MIPS), containing creatine and electrolytes (like those in a sports 
drink), on strength and power in weight-trained subjects. To improve upon past studies, this 
analysis aims to objectively evaluate a soluble creatine supplement versus placebo on 
strength and power in an athletic population. The results of this study will enhance our 
understanding of this supplement and how it may affect physical performance.   
 
I UNDERSTAND THAT: 
 
1. This experiment will begin with measurement of height, weight, body fat with a Bod 
Pod Unit, and body water determination using a bio-impedance unit. Height will be 
measured with a stadiometer and weight with a standard physician’s balance beam 
scale. Body fat will be measured with the subject in minimal clothing like a swim suit 
or spandex. The subject will enter a small chamber and remain seated for the duration 
of the test. There is a window in the chamber door which allows the subject to have 
visual contact with the researcher at all times. For determining total body water, an 
impedance device is used. For this test, you will lie on a table and have electrodes 
attached to your wrists and ankles. It takes less than a minute, and then the electrodes 
are removed. My participation for these tests will be approximately 30 minutes. 
 
2. Supplementation will be either treatment (creatine and electrolytes, like those in a 
sports drink) or placebo (sugar) for 6 weeks in a blinded fashion. Blinded is that 
neither the subject nor the researcher providing the numbered supplement will know 
whether the supplement is the treatment or placebo until the end of the 6-week period. 
Each week, the packet for that week will be picked up at the lab. For this study, 
consistent dietary and exercise programs should be maintained. During the first and 
sixth week of supplementation, I will keep a 3-day diet record and 3-day physical 
activity record that will be submitted for analysis. 
 
3. Both groups will undergo pre- and post-supplementation testing sessions to assess 
strength and power. Countermovement vertical jump testing will be assessed with a 
force platform, prior to maximal strength testing. After a dynamic warmup, two 
practice jumps will be allowed for familiarization with the test. Following this, three 
trials on the force plate will be completed. After completion of the countermovement 
jump trials, estimated one repetition maximums (1RM) for the squat and bench press 
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will be according to the National Strength and Conditioning Association (NSCA) 
testing procedures. A three repetition maximum will be determined, than the 
O’Conner formula used to estimate the 1RM. Velocity measurements during testing 
of both the back squat and bench press exercises will be taken with a PUSH armband. 
Subjects wear armbands during testing on the forearm. To operate, the armband will 
be turned on prior to the beginning of the session and synced with the PUSH Team 
monitor. Prior to initiating a set, the subject taps his/her icon on the Team screen. 
Once in position, prior to unracking the barbell, the subject will push the button on 
his/her armband to start recording. After completion of the set, the subject then will 
push the button again to terminate the recording. This procedure will be completed 
during squat and bench press. The total positive work performed during lifting will be 
determined using data collected via a single camera collecting at high speed. One 
passive retro reflective marker will be placed on the barbell to track vertical position. 
Force exerted by the lifter on the barbell at every time point during the motion will be 
calculated using video to derive the acceleration of the bar. Total work will then be 
calculated as the product of the average force on the bar and the positive 
displacement.  
 
4. There may be risks during the strength and power tests, such as falling during the 
vertical jump, but this will be minimized with a spotter. I understand that exercise can 
lead to muscular soreness, cramping, pain, and fatigue. During testing, there is a risk 
of experiencing muscle soreness that should disappear after a period of rest. I 
understand that if exercise testing is painful, I can stop at any time. In addition, I am 
aware that I could experience delayed onset muscle soreness (DOMS) after the 
session that could last for 24-72 hours. The safeguards that will be used minimize 
potential muscle soreness include a warm-up, acclimation, and cool down period. If I 
feel like I cannot or should not perform any of these tasks, I could opt out from the 
participation in this study. 
 
5. Possible benefits include that subjects may be have performance benefits associated 
with supplementation. The results of this study may aid in future research.  
 
6. There is twenty dollars ($20) compensation for my participation in the complete 
project: supplementation, pre- and post-testing. My participation is voluntary, I may 
choose to withdraw my consent and discontinue participation without penalty.  
 
7. All information collected is confidential. My signed consent form will be kept in a 
locked cabinet separate from the data collection forms for the project data. My name 
will not be associated with any of my data collected throughout the study. 
 
8. My signature on this form does not waive my legal rights of protection. 
 
9. Any questions you may have regarding the study procedures will be answered by the 
primary researchers (Lorrie Brilla, Dave Suprak) who can be contacted at 
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Lorrie.Brilla@wwu.edu  (360-650-3056) or Dave.Suprak@wwu.edu (360-650-2586).  
Any questions about your rights as a research subject should be directed to Janai 
Symons, the WWU Research Compliance Officer (RCO), 360-650-3082.  If any 
injury or adverse effect of this research is experienced you should contact Lorrie 
Brilla, Dave Suprak, or the RCO. 
 
 
 
 

 
I have read the above descriptions and agree to participate in this study. 
 
_______________________________________   _____________________ 
Participant’s Signature      Date 
 
_______________________________________ 
Participant’s PRINTED NAME 
 
 
Note: Please sign both copies of the form and retain the copy marked “Participant” 
                                                              
 
                                                                                                                     
  Participant Name (printed)                                        Date 
 
    
 Participant Signature 
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Appendix B: Hold Harmless Agreement 
 
Health and Human Development 
Department 
 
 
ACKNOWLEDGEMENT OF RISK AND HOLD HARMLESS AGREEMENT 
 
Acknowledgment of Risk: 
I hereby acknowledge that I have voluntarily chosen to participate in the activities of the Kinesiology and 
Physical Education Program (hereinafter called “Program”) through Western Washington University’s Health 
and Human Development Department.  I understand the risks involved. I recognize that the classes and other 
activities which include but are not limited to motor skills, fitness, outdoor recreation, games, sports, 
modified, creative, rhythmic, individual, dual and team, involve risk of injury and I agree to accept any and 
all risks associated with the activities, including but not limited to property damage or loss, minor bodily injury, 
severe bodily injury, illness and death.  Furthermore, I recognize that my participation in the Program involves 
activities incidental thereto, including but not limited to, travel to/from Program activities, limited availability 
of medical aid and the possible negligent or reckless conduct of other participants.  By voluntarily participating 
in the Program with the knowledge of the risks involved, I hereby agree to accept any and all inherent risks of 
property damage, bodily injury, or death.   
 
I understand that I am responsible for researching and evaluating the risks that I may face and am responsible 
for my actions.  Any activities that I may take part in, whether as a component of the Program or separate from 
it, will be considered to have been undertaken with my approval and understanding of any and all risks 
involved.   
 
Indemnification and Hold Harmless: 
In consideration of my participation in the Program and to the extent permitted by law, I agree to indemnify, 
defend and hold harmless Western Washington University, its trustees, officers, directors, employees, agents, 
volunteers and assigns from and against all claims arising out of or resulting from my participation in the 
Program.  “Claim” as used in this agreement means any financial loss, claim, suit, action, damage, or expense, 
including but not limited to attorney’s fees, attributable to bodily injury, sickness, disease or death, or injury to 
or destruction of tangible property including loss of use resulting therefrom.  In addition, I hereby voluntarily 
hold harmless Western Washington University, its trustees, officers, directors, employees, agents, volunteers 
and assigns from any and all claims, both present and future, that may be made by me, my family, estate, heirs 
or assigns. 
 
I hereby expressly agree to indemnify, defend and hold harmless Western Washington University, its trustees, 
officers, directors, employees, agents, volunteers and assigns for any claim arising out of my participation in the 
activity, except for claims arising out of the sole negligence or willful misconduct of Western Washington 
University, its trustees, officers, directors, employees, agents, volunteers and assigns. 
 
I understand that Western Washington University does not provide any medical, dental or life insurance to 
cover bodily injury, illness or death; nor insurance for personal property damage or loss; nor insurance for 
liability arising out of my negligent acts or omissions; and I acknowledge that I am completely responsible for 
my own insurance or financial resources to cover expenses related to these things.  
 
I further understand that this acknowledgement of risk and hold harmless is intended to be as broad and 
inclusive as permitted by the laws of the State of Washington, or any other applicable laws, and that if any 
portion hereof is held invalid, I agree that the balance shall, notwithstanding, continue in full legal force and 
effect. 
 
I agree that this acknowledgment of risk and hold harmless is effective for as long as I participate in the 
Program. 
I have read and understand this acknowledgement of risk and hold harmless agreement.  
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__________________________  _______________________________ ___________ 
Participant Name (please print)  Signature of Participant    Date 
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Appendix C: Subject Background Information Form 
BACKGROUND INFORMATION FORM 
Name:         Date:    
Height in inches: ____ Weight in lbs.: ____ 
Age:   Sex:  Birth date:     
Street Address:          
City:      State:   Zip:    
Phone: ____________  
In case of emergency notify:   Name:         
Phone Number:      Relationship:      
Have you had a physical examination within the past two years?     
Name of your physician:_______________ Phone Number:    
Do you have a family history of heart disease?     
If so, describe?          
Do you have any renal problems?         
Do you experience any uncomfortable sensations while exercising?    
How active are you? What type of exercise do you engage in and how many times a week do 
you exercise?_____________________________________ 
Do you drink alcohol?  If so, how much?     
Please list everything not already included on this questionnaire that might cause you 
problems in a strength or jump test: 
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Appendix D: Protocol Check List 
Albion Research Study Part I  
Fall  
Date   Time (Begun, 
Completed) 
 
Subject Number  Age (yrs)  
Height (cm)  Weight (kg)  
 
Injury History  
 
Dominant Limb Right   /   Left Years of Training 
(Strength & Power) 
 
 
Consent Form? Yes   /   No Videotaping Form? N/A 
Explanation of 
test? 
Yes   /   No Subject on Master 
Sheet? 
Yes   /   No 
Questions? Yes   /   No   
Room set-up?  Area around the equipment is free of obstructions and 
hazards 
 BIA equipment is next to the treatment table, electrodes 
included 
 Bod Pod is plugged in and ready to begin 
calibration/collection 
 Force plate is turned on and zeroed  
o Vertec is easily accessible near the force plate 
 Qualisys cameras on turned on and calibrated 
 Squat rack is in place and free from obstructions 
 Barbell and weights are in appropriate positions for use 
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Body Composition  
Bod Pod 
 
 
 Computer and equipment are plugged in & Turned on 
 Area around scale and equipment is clear  
 Calibration weights and cylinders are within close reach for 
calibration protocols  
  Researcher is logged into the computer 
o Guest 
o Podarama 
 Create new subject information for specific subject  
 Ensure that the subject is wearing appropriate clothing for 
testing 
o Blue cap worn to cover hair 
o No loose fitting  
 Follow onscreen directions for calibration of the scale and 
collection space 
o Directions are specifically given on screen and run 
through the entire process 
o Include weight of the subject for accuracy 
 Follow collection procedure on screen once calibration has 
be completed 
o On screen directions are given for entire collection 
process 
o Two trials are taken to ensure accuracy of 
measurement 
 Following collection, the subject can change back into their 
clothes and return the blue swim cap. Export all relevant 
data.  
 
Bio-Electrical 
Impedance   
 Treatment table is set up for comfortable positioning  
 Equipment is on a stable surface next to the table 
 Prep the subject for collection: 
o Right shoe and sock are removed  
o Lay down on the table in a supine position 
o Swab area with alcohol swabs prior to electrode 
placement 
 Place electrodes on the right hand and foot  
 Run collection and record relevant results from machine 
read-out 
 Remove electrodes from the subject 
 
Dynamic Warm-
Up 
 Jog on a treadmill for 2 minutes at 6 miles per hour 
 Walking knee hugs (5 repetitions on each leg) 
 Lunge to torso twist (5 repetitions on each leg) 
 Walking quad stretches (5 repetitions on each leg) 
 Inverted hamstring stretch (5 repetitions on each leg) 
 Wall slides (5 repetitions) 
 Cross-body shoulder slaps (5 repetitions) 
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 Push-ups (5 repetitions) 
 4 minute rest period 
 
Counter 
Movement Jump 
Protocol 
 Force plate is on and zeroed  
 The vertec is set up next to the force plate  
 Subjects are shown a demonstration of a countermovement 
jump with their hands on their hips 
 Subjects are allowed two practice trials to become 
accustomed to the protocol  
 Have the subject start off of the force plate to tare  
 Have the subject step onto the force plate to record their 
weight (in Newton’s) 
 Subjects will confirm they’re ready to proceed.  
 One researcher will start a countdown of “3,2,1, GO” 
o Collection will start at “1” 
o Subjects will be instructed to initiate movement at 
“GO” 
 Once subjects land, collection is concluded  
 Repeat the steps above for second trial  
 
 
Strength Session (1RM & Concentric Work) 
Date   Time (Begun, 
Completed) 
 
Subject Number  Age (yrs)  
Height (in)  Weight (lbs)  
Injury History 
 
 
 
Warm-up completed? 
Yes   /   No 
 Protocol prior to jump testing (above)  
 
Bench Press 
Technique 
Explained? 
Yes   /   No Back Squat 
Technique Explained? 
Yes   /   No 
Predicted 1-RM 
Bench Press (lbs) 
 Predicted 1-RM Back 
Squat (lbs) 
 
50%  50%  
75%  75%  
90%  90%  
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 Complete 10 repetitions at 
50% of their self-estimated 1-
RM 
 Rest 4 minutes 
 Complete 5 repetitions at 75% 
of their self-estimated 1-RM 
 Rest 4 minutes 
 Complete as many repetitions 
as possible (until failure) at 
90% of their self-estimated 1-
RM 
 
LOAD _________ lbs 
REPS TO FAILURE  ________ 
 Complete 10 repetitions at 50% of their 
self-estimated 1-RM 
 Rest 4 minutes 
 Complete 5 repetitions at 75% of their 
self-estimated 1-RM 
 Rest 4 minutes 
 Complete as many repetitions as possible 
(until failure) at 90% of their self-
estimated 1-RM 
 
 
LOAD _________ lbs 
REPS TO FAILURE  ________ 
Enter data into equation:              (1-RM = Load * (1+(0.025 * RTF)) 
 
Predicted 1-RM bench press: ________ lbs                            Predicted 1-RM back 
squat: ________ lbs                 
Following 1RM testing, determine load equivalent to 80% of their estimated 1RM. Have 
the subject perform their maximal number of repetitions at this load. During the set, 
collect video analysis using the Qualisys Camera system.  
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Appendix E. Raw Data 
Raw Data for the body composition testing 
  Pre Post 
Group 
# 
Body 
Density 
(g*cc^-1) 
Body Fat 
(%) 
Fat 
Free 
Mass 
(kg) 
Fat Mass 
(kg) 
Body 
Density 
(g*cc^-1) 
Body Fat 
(%) 
Fat Free 
Mass 
(kg) 
Fat Mass 
(kg) 
1 1.094 2.6 72.955 1.975 1.087 5.3 70.888 3.969 
1 1.037 27.3 43.984 16.522 1.045 23.7 44.131 13.73 
1 1.066 14.6 88.357 15.05 1.078 9 94.781 9.369 
1 1.044 24.3 59.863 19.216 1.056 18.6 64.664 14.822 
1 1.082 7.6 70.337 5.823 1.086 5.7 71.8 4.369 
1 1.069 13.2 57.478 8.752 1.07 12.7 58.301 8.463 
1 1.067 14.1 68.344 11.221 1.060 17.2 67.459 14.009 
1 1.048 22.1 55.766 15.859 1.054 19.4 56.85 13.699 
1 1.084 6.7 61.672 4.427 1.087 5.5 61.803 3.605 
1 1.05 21.6 41.857 11.527 1.053 20.14 42.289 10.664 
2 1.075 10.7 68.757 8.204 1.058 17.7 65.14 14.02 
2 1.081 7.8 66.726 5.638 1.076 9.9 67.738 7.415 
2 1.044 24.1 48.242 15.324 1.039 26.5 48.084 17.379 
2 1.095 2.2 66.698 1.473 1.083 7.2 68.74 5.322 
2 1.057 18.1 65.126 14.391 1.063 15.7 67.018 12.501 
2 1.075 10.4 56.096 6.491 1.08 8.5 58.602 5.467 
2 1.069 13.2 70.21 10.648 1.063 15.5 68.938 12.627 
2 1.048 22.5 52.686 15.316 1.051 20.8 52.08 13.685 
2 1.042 25.2 49.802 16.78 1.055 19 54.059 12.668 
2 1.051 20.9 51.806 13.704 1.054 19.5 54.084 13.069 
2 1.074 11.1 58.442 7.284 1.075 10.5 61.214 7.2 
 
Raw data for the body water analysis 
 Pre Post 
Group  
Total Body 
Water (L) 
Intra-Cellular 
Water (L) 
Extra-
Cellular 
Water (L) 
Total Body 
Water (L) 
Intra-Cellular 
Water (L) 
Extra-
Cellular 
Water (L) 
1 47.8 27.9 19.9 46.5 27.1 19.4 
1 31.4 16.9 14.4 30.7 16.7 14 
1 61.4 34.8 26.6 59.1 33.3 25.8 
1 40.6 23.6 17.1 40.3 23.5 16.9 
1 46.4 27.4 19 47.9 28.4 19.4 
1 37.8 22.2 15.5 37.4 22 15.4 
1 49.1 28.5 20.6 50 28.9 21 
1 33.9 19.5 14.4 35.1 20.1 14.9 
1 41.4 24.6 16.9 42 24.9 17.1 
2 43.8 25.7 18.1 43.2 25.1 18.1 
2 41.2 24.1 17.2 43 25.1 17.9 
2 29.8 15.7 14.1 31 16.4 14.6 
2 42.8 25.5 17.3 43.1 25.4 17.7 
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2 49.4 29.1 20.2 48.3 28.5 19.8 
2 39.2 23.5 15.7 40.8 24.3 16.5 
2 46.3 26.5 19.8 45.3 25.9 19.3 
2 30.7 15.9 14.8 28.1 14.4 13.8 
2 33.7 18 15.7 33.6 18.2 15.2 
2 36.9 22 14.9 38 22.7 15.3 
2 40.7 24.3 16.4 40.4 23.9 16.5 
 
 
Raw data for the akimbo countermovement jump 
  Pre Post 
Group 
# Peak Power 
Ave 
Power  Peak Power Ave Power 
1 6957.54 1165.4 6732.87 1088.45 
1 5175.22 401.66 5177.25 401.76 
1 7760.06 1744.11 7650.76 1706.68 
1 6370.13 1008.49 6828.59 1165.5 
1 7674.85 1424.19 7808.44 1469.94 
1 5860.72 654.23 5910.31 671.22 
1 6254.03 973.91 6792.45 1158.31 
1 5917.59 773.96 6006.65 804.46 
1 6583.97 943.22 6814.72 1022.25 
2 7265.46 1293.53 7146.04 1251.63 
2 5987.71 805.86 5738.74 720.59 
2 5285.38 471.44 5206.44 444.41 
2 6714.26 1009.96 6889.34 1069.93 
2 6688.28 941.47 7122.46 1090.17 
2 5944.23 1000.37 5977.63 1011.81 
2 6238.96 1188.03 6630.47 1116.62 
2 5644.92 626.75 5644.82 626.75 
2 5696.11 659.416 5567.58 615.44 
2 6560.7 928.96 6618.39 948.71 
2 6568.48 933.93 6512.81 914.86 
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Raw Data for the 1RM bench press and back squat 
 
 
Raw data for the back squat maximal repetition set at 80% 1RM  
 
 
 
 
 
 
 
 
 
 
 
Group # Bench Squat Bench Squat
1 74.09091 91.81818 77.44318 88.29545
1 53.69318 78.40909 54.88636 81.02273
1 138.4091 177 140.625 166.9318
1 96.70455 128.0682 99.31818 130.3977
1 112.1591 161.0795 112.5 163.6364
1 62.89773 57.27273 62.5 56.19545
1 112.1591 109.7727 107.5 112.3864
1 83.06818 107.3864 84.37727 105.0591
1 25.625 43.46591 25 48.29545
2 100.9091 N/A 106.8182 N/A
2 65.90909 75 70.90909 90.34091
2 34.94318 53.125 35.45455 53.69318
2 95.51136 138.5227 101.4773 137.5
2 125 155.9659 133.5227 165.5682
2 77.95455 90.625 84.54545 108.4091
2 36.59091 69.03409 40 79.20455
2 60 69.54545 64.09091 74.77273
2 41.93182 76.36364 40.56818 80.11364
2 41.53409 70.90909 43.63636 77.95455
2 78.23864 105.6818 73.97727 102.6136
2 72.38636 102.2727 84.03409 151.4205
2 76.36364 134.375 85.22727 171.6477
PostPre
grp # Total Conc. Work Mean RFD Peak Power Mean Power Peak Force Total Conc. Work Mean RFD Peak Power Mean Power Peak Force
1 2641.67 1298.4 1070.27 168.74 2457 2132.37 2333.77 1429.79 166.17 2603.62
1 4579.5 1823.33 2869.65 359 6069.48 4475.93 3063.63 3193.7 375.76 4714.57
1 8739.87 2989.31 6656.11 542.19 6736.62 8554.46 4560.8 4772.39 624.21 5803.9
1 1739.28 1268.67 1361.81 162.75 2121.55 924.46 1943.22 1575.92 182.66 2317.91
1 3899.19 2336.39 4117.44 324.39 5386.5 4206.91 3917.84 3017.51 357.52 4491.08
1 1736.57 1393.2 1682.03 158.46 2733.75 2514.35 1895.38 2359.87 188.96 3126.48
1 3571.32 2227.9 2580.47 262.07 3881.7 2626 4916.32 2877.97 315.95 3782.21
1 1474.2 1466.26 566.66 106.16 1247.52 1380.74 1065.22 705.35 85.69 1674.61
2 2468.53 991.16 1204.78 134.78 1978.16 1214.91 1141.7 1439.57 156.82 2146.05
2 4273.98 3548.04 5911.26 425.4 8208.78 3661.09 2232.78 1670.85 211.52 3440.5
2 6040.25 4111.58 5421.79 613.49 7022.25 7679.22 23794.19 4522.39 717.71 5924.25
2 2528.98 5876.43 1691.74 333.19 2818.47 4726.03 2909.45 2052.71 388.57 3038.4
2 1334.63 4245.33 1921.72 218.65 2475.16 1280.28 4032.48 1368.11 222.21 2160.98
2 3011.96 2006.02 3997.44 187.82 5279.24 3589.87 6033.07 2313.75 205.2 3244.91
2 2329.94 2006.81 2096.44 203.74 3076.16 2642.48 5048.65 2257.47 228.3 3411.94
2 2992.71 1909.92 1509.38 224.23 2907.7 3661.09 2232.78 1670.85 211.52 3440.5
Pre-Back Squat Post-Back Squat
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Raw data for the bench press maximal repetition set at 80% 1RM  
 
 
  
Grp # Total Conc. Work Mean RFD Peak power Mean Power Peak Force Total Conc. Work Mean RFD Peak power Mean Power Peak Force
1 2370.86 9837.5 1056.4 207.06 2298.52 2234 3154.54 1407.62 200.58 2204.92
1 1194.19 1493.39 630.67 96.14 1698.34 1238.91 2335.96 705.47 97.52 1717
1 3634.81 19153.66 2344.01 443.49 4395.97 2825.51 14814.94 2617.22 417.15 5566.62
1 2494 11811.19 1266.07 224.16 3183.79 2710.59 4252.29 1716.98 237.85 3984.95
1 2476.53 12325.99 1809.52 286.63 3664.76 2424.03 13440.08 1392.44 289.46 3179.74
1 1481.64 3072.07 1068.99 164.28 2088.9 1283.47 2703.55 1179.88 136.85 2412.9
1 1507.3 3677.35 819.52 127.45 1542.07 1541.88 1374.08 652.45 111.84 1748.25
1 1996.71 2839.04 1459.69 162.44 3057.26 2176.54 3701.89 1358.66 164.64 3152.17
1 759.1 1435.33 387.54 69 786.8 877.49 2691.43 631.62 65.45 1134.37
2 2260.38 4974.21 2819.92 178.71 6045.55 3280.73 2936.85 1203.55 255.02 2899.8
2 1887.73 1387.69 842.89 126.34 1995.67 2616.29 2362.94 925.76 166.39 1995.67
2 655.79 2168.69 319.09 57.29 899.84 847.01 1433.47 520.01 71.41 1320.05
2 2074.12 2593.79 1095.38 166.97 2949.75 3428.05 7839.54 1672.94 261.04 2811.07
2 2799.48 3905.46 1852.55 340.23 4192.2 3869.86 10890.43 2673.19 368.42 5257.8
2 1747.01 1449.87 1044.46 167.7 2784.56 2841.27 6702.22 1375.39 251.27 2855.25
2 1189.96 2877.21 673.04 149.08 919.51 691.94 3296.1 704.98 139.25 1140.75
2 3004.25 6940.45 1068.37 135.64 2152.02 2577.53 2162.2 1476 186.65 2536.9
2 718.52 728.98 446.67 98.67 1198.43 823.07 855.1 782.29 101.78 1478.25
2 1038.56 3073.11 856.35 147.3 2475.33 1586.69 2320.9 950.51 144.79 2292.05
2 1877.66 4727.93 1033.59 218.1 2169.2 2145.43 4544.4 1348.02 194.18 2692.84
2 2993.65 8616.83 1565.82 249.94 2996.63 3428.05 7839.54 1672.94 261.04 2811.07
Pre-Bench Press Post-Bench Press
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Appendix F. Statistical Outputs 
 
Body Composition 
 
Tests of Within-Subjects Contrasts 
Source Measure test Type III Sum of 
Squares 
df Mean Square F Sig. 
test 
BodyDensity Linear 1.299E-005 1 1.299E-005 .430 .520 
BodyFat Linear 4.210 1 4.210 .725 .405 
FatFree Linear 13.199 1 13.199 4.633 .044 
FatMass Linear 1.730 1 1.730 .463 .504 
test * Group 
BodyDensity Linear 5.966E-005 1 5.966E-005 1.974 .176 
BodyFat Linear 11.596 1 11.596 1.998 .174 
FatFree Linear .133 1 .133 .047 .831 
FatMass Linear 9.673 1 9.673 2.591 .124 
Error(test) 
BodyDensity Linear .001 19 3.023E-005   
BodyFat Linear 110.281 19 5.804   
FatFree Linear 54.130 19 2.849   
FatMass Linear 70.934 19 3.733   
 
Tests of Within-Subjects Contrasts 
Source Measure test Partial Eta Squared 
test 
BodyDensity Linear .022 
BodyFat Linear .037 
FatFree Linear .196 
FatMass Linear .024 
test * Group 
BodyDensity Linear .094 
BodyFat Linear .095 
FatFree Linear .002 
FatMass Linear .120 
Error(test) 
BodyDensity Linear  
BodyFat Linear  
FatFree Linear  
FatMass Linear  
 
Tests of Between-Subjects Effects 
Transformed Variable: Average 
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Source Measure Type III Sum of 
Squares 
df Mean Square F Sig. 
Intercept 
BodyDensity 47.523 1 47.523 91798.228 .000 
BodyFat 9356.538 1 9356.538 95.879 .000 
FatFree 157701.625 1 157701.625 608.406 .000 
FatMass 4667.805 1 4667.805 109.605 .000 
Group 
BodyDensity 3.585E-005 1 3.585E-005 .069 .795 
BodyFat 5.911 1 5.911 .061 .808 
FatFree 74.452 1 74.452 .287 .598 
FatMass 1.687 1 1.687 .040 .844 
Error 
BodyDensity .010 19 .001   
BodyFat 1854.147 19 97.587   
FatFree 4924.891 19 259.205   
FatMass 809.160 19 42.587   
 
Tests of Between-Subjects Effects 
Transformed Variable: Average 
Source Measure Partial Eta Squared 
Intercept 
BodyDensity 1.000 
BodyFat .835 
FatFree .970 
FatMass .852 
Group 
BodyDensity .004 
BodyFat .003 
FatFree .015 
FatMass .002 
Error 
BodyDensity  
BodyFat  
FatFree  
FatMass  
 
Body Water Analysis 
 
Tests of Within-Subjects Contrasts 
Source Measure test Type III Sum of 
Squares 
df Mean Square F 
test 
TotalBodWater Linear .009 1 .009 .011 
TotalBodWaterPerc Linear .000 1 .000 1.918 
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IntraCellularLiters Linear .021 1 .021 .070 
IntracelluarPercentage Linear .000 1 .000 1.813 
ExtracellularLiters Linear .000 1 .000 .002 
ExtraCellularPercetange Linear 6.194E-005 1 6.194E-005 2.677 
test * Groups 
TotalBodWater Linear .033 1 .033 .039 
TotalBodWaterPerc Linear .000 1 .000 2.368 
IntraCellularLiters Linear .001 1 .001 .003 
IntracelluarPercentage Linear .000 1 .000 2.674 
ExtracellularLiters Linear .025 1 .025 .181 
ExtraCellularPercetange Linear 4.470E-005 1 4.470E-005 1.932 
Error(test) 
TotalBodWater Linear 15.235 18 .846  
TotalBodWaterPerc Linear .003 18 .000  
IntraCellularLiters Linear 5.354 18 .297  
IntracelluarPercentage Linear .001 18 6.923E-005  
ExtracellularLiters Linear 2.515 18 .140  
ExtraCellularPercetange Linear .000 18 2.313E-005  
 
Tests of Within-Subjects Contrasts 
Source Measure test Sig. Partial Eta Squared 
test 
TotalBodWater Linear .917 .001 
TotalBodWaterPerc Linear .183 .096 
IntraCellularLiters Linear .794 .004 
IntracelluarPercentage Linear .195 .092 
ExtracellularLiters Linear .967 .000 
ExtraCellularPercetange Linear .119 .129 
test * Groups 
TotalBodWater Linear .845 .002 
TotalBodWaterPerc Linear .141 .116 
IntraCellularLiters Linear .956 .000 
IntracelluarPercentage Linear .119 .129 
ExtracellularLiters Linear .676 .010 
ExtraCellularPercetange Linear .181 .097 
Error(test) 
TotalBodWater Linear   
TotalBodWaterPerc Linear   
IntraCellularLiters Linear   
IntracelluarPercentage Linear   
ExtracellularLiters Linear   
ExtraCellularPercetange Linear   
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Tests of Between-Subjects Effects 
Transformed Variable: Average 
Source Measure Type III Sum of 
Squares 
df Mean Square F Sig. 
Intercept 
TotalBodWater 67840.528 1 67840.528 602.702 .000 
TotalBodWaterPerc 12.663 1 12.663 1834.382 .000 
IntraCellularLiters 22575.484 1 22575.484 496.868 .000 
IntracelluarPercentage 4.208 1 4.208 1053.174 .000 
ExtracellularLiters 12132.400 1 12132.400 723.098 .000 
ExtraCellularPercetange 2.269 1 2.269 4169.188 .000 
Groups 
TotalBodWater 139.444 1 139.444 1.239 .280 
TotalBodWaterPerc .003 1 .003 .413 .529 
IntraCellularLiters 51.478 1 51.478 1.133 .301 
IntracelluarPercentage .001 1 .001 .324 .576 
ExtracellularLiters 21.413 1 21.413 1.276 .273 
ExtraCellularPercetange .000 1 .000 .545 .470 
Error 
TotalBodWater 2026.091 18 112.561   
TotalBodWaterPerc .124 18 .007   
IntraCellularLiters 817.841 18 45.436   
IntracelluarPercentage .072 18 .004   
ExtracellularLiters 302.011 18 16.778   
ExtraCellularPercetange .010 18 .001   
 
Tests of Between-Subjects Effects 
Transformed Variable: Average 
Source Measure Partial Eta Squared 
Intercept 
TotalBodWater .971 
TotalBodWaterPerc .990 
IntraCellularLiters .965 
IntracelluarPercentage .983 
ExtracellularLiters .976 
ExtraCellularPercetange .996 
Groups 
TotalBodWater .064 
TotalBodWaterPerc .022 
IntraCellularLiters .059 
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IntracelluarPercentage .018 
ExtracellularLiters .066 
ExtraCellularPercetange .029 
Error 
TotalBodWater  
TotalBodWaterPerc  
IntraCellularLiters  
IntracelluarPercentage  
ExtracellularLiters  
ExtraCellularPercetange  
 
Akimbo Countermovement Jump 
Tests of Within-Subjects Contrasts 
Source Measure test Type III Sum of 
Squares 
df Mean Square F Sig. 
test 
FlightTime Linear .000 1 .000 .876 .362 
PeakPower Linear 72887.958 1 72887.958 2.756 .114 
MeanPower Linear 3948.480 1 3948.480 1.408 .251 
test * Group 
FlightTime Linear .001 1 .001 2.876 .107 
PeakPower Linear 19136.316 1 19136.316 .724 .406 
MeanPower Linear 5897.393 1 5897.393 2.103 .164 
Error(test) 
FlightTime Linear .009 18 .001   
PeakPower Linear 476080.302 18 26448.906   
MeanPower Linear 50488.880 18 2804.938   
 
Tests of Within-Subjects Contrasts 
Source Measure test Partial Eta Squared 
test 
FlightTime Linear .046 
PeakPower Linear .133 
MeanPower Linear .073 
test * Group 
FlightTime Linear .138 
PeakPower Linear .039 
MeanPower Linear .105 
Error(test) 
FlightTime Linear  
PeakPower Linear  
MeanPower Linear  
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Tests of Between-Subjects Effects 
Transformed Variable: Average 
Source Measure Type III Sum of 
Squares 
df Mean Square F Sig. 
Intercept 
FlightTime 9.995 1 9.995 665.708 .000 
PeakPower 
1629038676.12
9 
1 
1629038676.12
9 
1558.306 .000 
MeanPower 36732068.470 1 36732068.470 177.023 .000 
Group 
FlightTime .005 1 .005 .348 .562 
PeakPower 976815.195 1 976815.195 .934 .347 
MeanPower 188472.346 1 188472.346 .908 .353 
Error 
FlightTime .270 18 .015   
PeakPower 18817033.718 18 1045390.762   
MeanPower 3734971.418 18 207498.412   
 
Tests of Between-Subjects Effects 
Transformed Variable: Average 
Source Measure Partial Eta Squared 
Intercept 
FlightTime .974 
PeakPower .989 
MeanPower .908 
Group 
FlightTime .019 
PeakPower .049 
MeanPower .048 
Error 
FlightTime  
PeakPower  
MeanPower  
 
1RM Testing 
Tests of Within-Subjects Contrasts 
Source Measure test Type III Sum of 
Squares 
df Mean Square F Sig. 
test 
Bench Linear 263.821 1 263.821 8.199 .010 
Squat Linear 1920.909 1 1920.909 5.197 .034 
test * Group 
Bench Linear 145.292 1 145.292 4.515 .047 
Squat Linear 2064.529 1 2064.529 5.586 .029 
Error(test) 
Bench Linear 611.361 19 32.177   
Squat Linear 7022.670 19 369.614   
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Tests of Within-Subjects Contrasts 
Source Measure test Partial Eta Squared 
test 
Bench Linear .301 
Squat Linear .215 
test * Group 
Bench Linear .192 
Squat Linear .227 
Error(test) 
Bench Linear  
Squat Linear  
 
 
Tests of Between-Subjects Effects 
Transformed Variable: Average 
Source Measure Type III Sum of 
Squares 
df Mean Square F Sig. Partial Eta 
Squared 
Intercept 
Bench 1209285.349 1 1209285.349 124.033 .000 .867 
Squat 2140580.337 1 2140580.337 145.969 .000 .885 
Group 
Bench 8887.158 1 8887.158 .912 .352 .046 
Squat 995.667 1 995.667 .068 .797 .004 
Error 
Bench 185244.094 19 9749.689    
Squat 278627.887 19 14664.626    
 
Maximal Repetition Sets (Back Squat) 
 
Tests of Within-Subjects Contrasts 
Source Measure test Type III Sum of 
Squares 
df Mean Square F 
test 
Totalconcwork Linear 113717.997 1 113717.997 .287 
MeanRFD Linear 31249512.613 1 31249512.613 2.399 
PeakRFD Linear 
111799836057.
547 
1 
111799836057.
547 
2.103 
MeanPower Linear 1427.249 1 1427.249 .585 
PeakPower Linear 1725520.001 1 1725520.001 2.153 
PeakFor Linear 2575388.884 1 2575388.884 2.779 
test * Group 
Totalconcwork Linear 793916.554 1 793916.554 2.003 
MeanRFD Linear 5983283.115 1 5983283.115 .459 
PeakRFD Linear 
63888956272.9
67 
1 
63888956272.9
67 
1.202 
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MeanPower Linear 1412.594 1 1412.594 .579 
PeakPower Linear 940818.167 1 940818.167 1.174 
PeakFor Linear 731641.682 1 731641.682 .789 
Error(test) 
Totalconcwork Linear 5548473.110 14 396319.508  
MeanRFD Linear 182395545.055 14 13028253.218  
PeakRFD Linear 
744135533714.
672 
14 
53152538122.4
77 
 
MeanPower Linear 34160.036 14 2440.003  
PeakPower Linear 11220803.674 14 801485.977  
PeakFor Linear 12976272.645 14 926876.618  
 
Tests of Within-Subjects Contrasts 
Source Measure test Sig. Partial Eta Squared 
test 
Totalconcwork Linear .601 .020 
MeanRFD Linear .144 .146 
PeakRFD Linear .169 .131 
MeanPower Linear .457 .040 
PeakPower Linear .164 .133 
PeakFor Linear .118 .166 
test * Group 
Totalconcwork Linear .179 .125 
MeanRFD Linear .509 .032 
PeakRFD Linear .291 .079 
MeanPower Linear .459 .040 
PeakPower Linear .297 .077 
PeakFor Linear .389 .053 
Error(test) 
Totalconcwork Linear   
MeanRFD Linear   
PeakRFD Linear   
MeanPower Linear   
PeakPower Linear   
PeakFor Linear   
 
 
Tests of Between-Subjects Effects 
Transformed Variable: Average 
Source Measure Type III Sum of 
Squares 
df Mean Square F Sig. 
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Intercept 
Totalconcwork 368783709.934 1 368783709.934 42.959 .000 
MeanRFD 382399719.913 1 382399719.913 22.766 .000 
PeakRFD 
1564393234888
7.908 
1 
1564393234888
7.908 
69.039 .000 
MeanPower 2567281.696 1 2567281.696 49.328 .000 
PeakPower 209547246.441 1 209547246.441 49.335 .000 
PeakFor 447917040.994 1 447917040.994 81.822 .000 
Group 
Totalconcwork 96895.724 1 96895.724 .011 .917 
MeanRFD 35323588.455 1 35323588.455 2.103 .169 
PeakRFD 
3023309188.80
0 
1 
3023309188.80
0 
.013 .910 
MeanPower 2859.003 1 2859.003 .055 .818 
PeakPower 1421.911 1 1421.911 .000 .986 
PeakFor 63452.578 1 63452.578 .012 .916 
Error 
Totalconcwork 120184538.872 14 8584609.919   
MeanRFD 235154242.076 14 16796731.577   
PeakRFD 
3172357998118
.401 
14 
226596999865.
600 
  
MeanPower 728627.756 14 52044.840   
PeakPower 59464093.274 14 4247435.234   
PeakFor 76640472.400 14 5474319.457   
 
Tests of Between-Subjects Effects 
Transformed Variable: Average 
Source Measure Partial Eta Squared 
Intercept 
Totalconcwork .754 
MeanRFD .619 
PeakRFD .831 
MeanPower .779 
PeakPower .779 
PeakFor .854 
Group 
Totalconcwork .001 
MeanRFD .131 
PeakRFD .001 
MeanPower .004 
PeakPower .000 
PeakFor .001 
Error Totalconcwork  
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MeanRFD  
PeakRFD  
MeanPower  
PeakPower  
PeakFor  
 
Maximal Repetition Sets (Bench Press) 
 
Tests of Within-Subjects Contrasts 
Source Measure test Type III Sum of 
Squares 
df Mean Square F 
test 
TotalConcWork Linear 461769.456 1 461769.456 3.759 
MeanRFD Linear 3093952.181 1 3093952.181 .526 
PeakRFD Linear 
4200761742.22
7 
1 
4200761742.22
7 
.322 
PeakPower Linear 138075.659 1 138075.659 1.152 
MeanPower Linear 1462.584 1 1462.584 3.070 
PeakForce Linear 110907.944 1 110907.944 .307 
test * Group 
TotalConcWork Linear 799798.367 1 799798.367 6.510 
MeanRFD Linear 19026574.916 1 19026574.916 3.236 
PeakRFD Linear 
9769654964.47
0 
1 
9769654964.47
0 
.750 
PeakPower Linear 6305.099 1 6305.099 .053 
MeanPower Linear 3525.838 1 3525.838 7.402 
PeakForce Linear 266966.175 1 266966.175 .740 
Error(test) 
TotalConcWork Linear 2334300.864 19 122857.940  
MeanRFD Linear 111707342.098 19 5879333.795  
PeakRFD Linear 
247597078262.
501 
19 
13031425171.7
11 
 
PeakPower Linear 2277165.284 19 119850.804  
MeanPower Linear 9050.822 19 476.359  
PeakForce Linear 6856233.743 19 360854.408  
 
Tests of Within-Subjects Contrasts 
Source Measure test Sig. Partial Eta Squared 
test 
TotalConcWork Linear .068 .165 
MeanRFD Linear .477 .027 
PeakRFD Linear .577 .017 
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PeakPower Linear .297 .057 
MeanPower Linear .096 .139 
PeakForce Linear .586 .016 
test * Group 
TotalConcWork Linear .019 .255 
MeanRFD Linear .088 .146 
PeakRFD Linear .397 .038 
PeakPower Linear .821 .003 
MeanPower Linear .014 .280 
PeakForce Linear .400 .037 
Error(test) 
TotalConcWork Linear   
MeanRFD Linear   
PeakRFD Linear   
PeakPower Linear   
MeanPower Linear   
PeakForce Linear   
 
 
Tests of Between-Subjects Effects 
Transformed Variable: Average 
Source Measure Type III Sum of 
Squares 
df Mean Square F Sig. 
Intercept 
TotalConcWork 169243357.619 1 169243357.619 110.842 .000 
MeanRFD 
1105207667.41
8 
1 
1105207667.41
8 
36.642 .000 
PeakRFD 
8217804285909
.402 
1 
8217804285909
.402 
95.199 .000 
PeakPower 62013392.987 1 62013392.987 93.623 .000 
MeanPower 1480873.011 1 1480873.011 86.021 .000 
PeakForce 277353516.164 1 277353516.164 97.027 .000 
Group 
TotalConcWork 208004.066 1 208004.066 .136 .716 
MeanRFD 55052964.794 1 55052964.794 1.825 .193 
PeakRFD 
6343761789.85
9 
1 
6343761789.85
9 
.073 .789 
PeakPower 20929.880 1 20929.880 .032 .861 
MeanPower 962.055 1 962.055 .056 .816 
PeakForce 148757.840 1 148757.840 .052 .822 
Error TotalConcWork 29010869.291 19 1526887.857   
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MeanRFD 573089535.794 19 30162607.147   
PeakRFD 
1640124302072
.833 
19 
86322331688.0
44 
  
PeakPower 12585126.802 19 662375.095   
MeanPower 327088.549 19 17215.187   
PeakForce 54311902.649 19 2858521.192   
 
Tests of Between-Subjects Effects 
Transformed Variable: Average 
Source Measure Partial Eta Squared 
Intercept 
TotalConcWork .854 
MeanRFD .659 
PeakRFD .834 
PeakPower .831 
MeanPower .819 
PeakForce .836 
Group 
TotalConcWork .007 
MeanRFD .088 
PeakRFD .004 
PeakPower .002 
MeanPower .003 
PeakForce .003 
Error 
TotalConcWork  
MeanRFD  
PeakRFD  
PeakPower  
MeanPower  
PeakForce  
 
